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Cell lines: 4T1 (murine breast carcinoma), MDA-MB-231 (human breast carcinoma), and 
LoVo (human colon carcinoma) cell lines were obtained from ATCC. 4T1 cells were grown 
in RPMI 1640 (Life Technologies Cat # 22400-089) supplemented with 10 % FBS and non-
essential amino acids. MDA-MB-231 cells were grown in MEM (Life Technologies Cat # 
11095-080) supplemented with 10 % FBS, non-essential amino acids and sodium pyruvate. 
LoVo were grown in DMEM/ F-12 (1:1) medium (Life Technologies Cat # 10565-018) 
supplemented with 10 % FBS. 
Cytotoxicity assay: Cells in 100 µL medium were cultured in a 96-well plate at the following 
cell densities such that confluence upon cell harvest was approximately 80 %: For 1 day 
assay, 4T1 cells = 3000 cells per well; MDA-MB-231 cells = 8000 cells per well; LoVo 
cells = 12000 cells per well. For 4 day assay, 4T1 cells = 1000 cells per well; MDA-MB-231 
cells = 4000 cells per well; LoVo cells = 5000 cells per well. Cells were maintained in a 
humidified chamber (37ºC, 5 % CO2) overnight, then the cells were treated with compounds 
by adding 50 µL of 3X stocks in duplicate at 10 concentrations. Cells were incubated with 
compounds for one or four days. On the specified harvest day, 30 µL of Celltiter 96 Aqueous 
One Solution (MTS reagents; Promega, Cat # G3582) was added to the cells and incubated 
1.5 h at 37ºC, then absorbance was measured at 490 nm on a Victor plate reader (Perkin 
Elmer, Waltham, MA). Relative cell viability was determined as a percentage of untreated 
control wells. IC50 values were calculated using four parameter logistic model #203 with 
XLfit v4.2 (IDBS, Guildford, Surry, UK). 
Scratch wound healing assay: Cells (200,000 cells per well) were seeded into a 24-well-
tissue culture plate and allowed to grow in a humidified chamber (37ºC, 5 % CO2). The next 
day, the confluent monolayer of cells was scratched with a sterile pipette tip using a straight 
edge to create an empty space of approximately 1 mm width in the middle of the well. Cells 
were then washed once with media to remove debris. Fresh media containing compounds at 
various concentrations were added to wells and incubated overnight in a humidified chamber. 
Migration was quantified by computer-based pixel calculation of the clearing, and data are 
reported as percent of control vs. DMSO treated wells. 
Platypus cell migration assay: Cells were seeded into a 96-well Collagen-coated Platypus 
plate (Platypus technologies Cat No. CMACC1.101) with cell seeding stoppers in place and 
incubated overnight in a humidified chamber (37ºC, 5 % CO2). Stoppers were removed and 
the cells washed gently with 100 µL sterile PBS to remove unattached cells. Fresh media (100 
µl) with or without compounds in DMSO (6 replicates/compound) was added to each well 
and the plates were incubated for 24 h in a humidified chamber to allow migration. Reference 
wells for pre-migration controls (time = 0) were obtained by leaving the cell stoppers in place 
until the end of the migration period. Migration was stopped by removing the media then cells 




. Cells were then 





 for 30-60 min at 37ºC. The Oris Detection Mask was attached to the 
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plate bottom and fluorescence from the migrated cells was read in a microplate reader at 
485/528 nm excitation /emission. Data are normalized to DMSO-treated control wells. 
Transwell migration assay: Cells were starved overnight in serum-free media then collected 
by trypsinization, counted, and aliquoted into 1.5 mL centrifuge tubes (0.5 million cells in 1.5 
mL serum-free medium). Compounds in DMSO were added to the cells in quadruplicate and 
incubated for one hour at room temperature. These pre-treated cells were then added to the 
inserts of a 24-multiwell Insert System (BD Falcon, Cat No. 351185) at 300 µL/insert. 
Migration was started by lowering the inserts onto a 24-well plate containing complete 
medium (1 mL) with the same drug concentration used for the corresponding insert. Blank 
samples received DMSO in serum-free media in both inserts and bottom wells. Plates were 
incubated for 24 h in a humidified chamber (37ºC, 5 % CO2) to allow cell migration. At the 
harvest time point, media in inserts and bottom wells were discarded and the inserts were 
dipped quickly into a feeder tray (BD Falcon, Cat No. 351186) containing PBS to wash the 
outside of the inserts. Inserts were carefully washed twice with PBS, then lowered into a 24-
well plate (BD Falcon 353047) containing 0.5 mL of 1.7 µg/mL calcein AM (R&D Systems, 
Cat No. 4892-010-K) in cell dissociation solution (Gibco, Cat No. 13151-014 ). After 30 min 
incubation at 37ºC, the inserts were removed and fluorescence at 485/528 nm 
excitation/emission was read in a fluorescence plate reader. Migration is calculated by 
































Figure S-1. Structure of cycloalkyne 63 in the solid state.  
 
C20 H30 O5, Mr = 350.44 g·mol
-1
, colorless block, crystal size 0.33 x 0.32 x 0.15 mm, 
orthorhombic, space group P212121, a = 7.7235(3) Å, b = 14.4643(6) Å, c = 16.7847(7) Å, 
V = 1875.10(13) Å
3
, T = 100 K, Z = 4, Dcalc = 1.241 g·cm
3
,  = 1.54178 Å, (Cu-K) = 
0.712 mm-1, Semi-empirical absorption correction (Tmin = 0.76, Tmax = 0.91), Bruker AXS X8 
Proteum diffractometer, diffractometer, 4.03 <  < 67.05°, 42749 measured reflections, 3326 
independent reflections, 3243 reflections with I > 2 (I), Structure solved by direct methods 




 to R1 = 0.026 [I > 2(I)], wR2 = 0.064, 232 
parameters, H atoms riding, S = 1.067, absolute structure parameter = –0.04(13), residual 
electron density +0.1 / –0.2 e Å-3.  
The anisotropic displacement parameters are drawn at the 50 % probability level; hydrogen 
atoms are omitted for clarity. CCDC 913898 contains the supplementary crystallographic 
data for this paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif 
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General. All reactions were carried out under Ar in flame-dried glassware. The solvents used 
were purified by distillation over the drying agents indicated and were transferred under Ar: 
THF, Et2O, CH2Cl2, HMPA (CaH2), hexane, toluene (Na/K), MeOH (Mg). Flash 
chromatography (FC): Merck silica gel 60 (230–400 mesh). NMR: Spectra were recorded on 
Bruker AMX 300, AV 400, or AVIII 600 spectrometer in the solvents indicated; chemical 
shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals 
were used as references and the chemical shifts converted to the TMS scale (CDCl3: δC ≡ 77.0 
ppm; residual CHCl3 in CDCl3: δH ≡ 7.26 ppm). IR: Spectrum One (Perkin-Elmer) 
spectrometer, wavenumbers (~ ) in cm−1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: 
ESQ3000 (Bruker), accurate mass determinations: Bruker APEX III FT-MS (7 T magnet) or 
Mat 95 (Finnigan). Unless stated otherwise, all commercially available compounds (Fluka, 
Lancaster, Aldrich) were used as received. 
The preparation of compounds 26-33 is described in detail in the Supporting Information of 




Compound S1: O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate 
(HBTU, 243 mg, 0.64 mmol) and triethylamine (120 µL, 
0.87 mmol) were added to a solution of 2-(2,6-
dioxopiperidin-4-yl)acetic acid 41a (100 mg, 0.58 mmol)
2
 in 
THF (6 mL). The mixture was stirred at ambient temperature 
for 2 h before naphthalene-2-thiol (103 mg, 0.64 mmol) was 
added. Stirring was continued for 1.5 h before all volatile materials were evaporated. The 
residue was purified by flash chromatography (hexanes/EtOAc, 2/1) to give product S1 as a 
white solid (200 mg, quant.). 
1
H NMR (400 MHz, CDCl3):  = 8.10 (br s, 1H), 7.94 (s, 1H), 
7.91–7.82 (m, 3H), 7.58–7.51 (m, 2H), 7.43 (dd, J = 8.5, 1.8 Hz, 1H), 2.84 (d, J = 4.0 Hz, 
1H), 2.81–2.71 (m, 4H), 2.47–2.37 ppm (m, 2H); 13C NMR (100 MHz, CDCl3):  = 195.0 
(C), 170.9 (C), 134.5 (CH), 133.5 (C), 133.4 (C), 130.6 (CH), 129.0 (CH), 128.0 (CH), 127.8 
(CH), 127.4 (CH), 126.7 (CH), 123.9 (C), 47.3 (CH2), 37.1 (CH2), 27.6 ppm (CH); MS (EI): 
m/z (%): 313 (9) [M]
+
, 160 (100), 128 (4), 115 (22), 112 (10), 55 (8); HRMS (ESI): m/z: calcd 
for C17H15NO3SNa [M + Na]
+
: 336.0665; found 336.0667. 
Compound 41b: Palladium on charcoal (5 % w/w, 180 mg) and triethylsilane (2.2 mL, 13.4 
mmol) were added to a solution of thioester S1 (420 mg, 1.34 mmol) in 
THF (5 mL) and the resulting suspension was stirred for 7 h before it was 
diluted with acetone (20 mL) and filtered through a pad of Celite. The 
filtrate was evaporated and the residue purified by flash chromatography 
(hexanes/EtOAc, 2/8  1/9) to give aldehyde 41b as a white solid (125 
mg, 60 %). 
1
H NMR (400 MHz, CDCl3):  = 9.78 (s, 1H), 8.10 (br s, 1H), 2.82–2.71 (m, 3H), 
2.61 (d, J = 6.1 Hz, 2H), 2.36 ppm (dd, J = 17.5, 10.5 Hz, 2H); 
13
C NMR (100 MHz, CDCl3): 
 = 198.6 (C), 171.1 (C), 47.8 (CH2), 37.2 (CH2), 24.6 ppm (CH); MS (EI): m/z (%): 155 
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, 127 (82), 112 (17), 99 (23), 84 (16), 69 (15), 55 (32), 42 (100), 39 (38), 29 (24); 
HRMS (EI): m/z: calcd for C7H9NO3Na [M]
+
: 155.0582; found 155.0581. 
Compound S2. NaH (855 mg, 35.6 mmol) was added in several portions to a solution of tert-
butyl acetoacetate 34 (5.3 mL, 32.4 mmol) in THF (65 mL) at 
0 °C. After the gas evolution had ceased, nBuLi (1.6 M in 
hexanes, 21.3 mL, 34.0 mmol) was added dropwise before a 
solution of 1-bromo-2-butyne (5.39 g, 40.5 mmol) was slowly 
introduced via canula. Stirring was continued for 1 h at 0 °C before the resulting mixture was 
poured into a mixture of Et2O and HCl (2 M). The aqueous layer was extracted with Et2O and 
the combined organic layers were dried over MgSO4 and evaporated. The residue was 
purified by flash chromatography (hexanes/EtOAc, 95/5  80/20) to afford product S2 as a 
yellow oil (6.56 g, 96 %). 
1
H NMR (400 MHz, CDCl3):  = 3.37 (s, 2H), 2.73 (t, J = 7.3 Hz, 
2H), 2.41 (tq, J = 7.3, 2.5 Hz, 2H), 1.75 (t, J = 2.5 Hz, 3H), 1.47 ppm (s, 9H); 
13
C NMR (100 
MHz, CDCl3):  = 201.7 (C), 166.4 (C), 82.2 (C), 77.5 (C), 76.3 (C), 50.8 (CH2), 42.3 (CH2), 
28.1 (CH3), 13.4 (CH2), 3.6 ppm (CH3); IR (film): 2979, 2923, 1725, 1393, 1353, 1254, 1150, 
1172, 1030, 966, 907, 841, 795, 670 cm
-1
; MS (EI): m/z (%): 195 (0.6), 155 (2), 154 (10), 153 
(13), 139 (28), 137 (17), 109 (6), 108 (14), 96 (7), 95 (100), 94 (5), 67 (25), 66 (6), 65 (6), 59 
(7), 57 (96), 53 (6), 43 (7), 41 (31), 39 (8), 29 (10), 27 (5); HRMS (ESI): m/z: calcd for 
C12H18O3Na [M+Na]
+
: 233.1147; found 233.1148. 
Compound S3. NaBH4 (3.93 g, 103.8 mmol) was added in several portions to a solution of 
ketone S2 (7.29 g, 34.6 mmol) in THF (200 mL) at 0 °C. After 
stirring for 3 h at ambient temperature, the reaction was 
quenched with sat. aq. NH4Cl and diluted with tert-butyl methyl 
ether. The aqueous layer was extracted with tert-butyl methyl 
ether and the combined extracts were dried over MgSO4 and evaporated. The residue was 
purified by flash chromatography (hexanes/EtOAc, 95/5  90/10) to give product S3 as a 
colorless oil (5.15 g, 70 %). 
1
H NMR (400 MHz, CDCl3):  = 4.09 (dddd, J = 12.4, 8.4, 4.1, 
4.1 Hz, 1H), 3.15 (d, J = 3.5 Hz, 1H), 2.44 (dd, J = 16.4, 3.3 Hz, 1H), 2.35 (dd, J = 16.4, 8.8 
Hz, 1H), 2.28 (tq, J = 7.3, 2.5 Hz, 2H), 1.77 (t, J = 2.5 Hz, 3H), 1.70-1.54 (m, 2H), 1.47 ppm 
(s, 9H) ; 
13
C NMR (100 MHz, CDCl3):  = 172.4 (C), 81.4 (C), 78.5 (C), 76.1 (C), 67.2 (CH), 
42.3 (CH2), 35.6 (CH2), 28.2 (CH3), 15.2 (CH2), 3.6 ppm (CH3); IR (film): 3464, 2978, 2921, 
1723, 1435, 1393, 1367, 1304, 1253, 1147, 1071, 943, 844, 761 cm
-1
; MS (EI): m/z (%): 197 
(0.4), 139 (6), 138 (18), 121 (6), 110 (5), 97 (39), 96 (28), 95 (11), 93 (17), 81 (6), 79 (7), 69 
(8), 67 (9), 59 (14), 57 (100), 56 (10), 55 (7), 53 (10), 43 (20), 41 (41), 39 (12), 29 (16), 27 
(7); HRMS (ESI): m/z: calcd for C12H20O3Na [M+Na]
+
: 235.1305; found 235.1304. 
Compound S4. Triethylamine (5.0 mL, 36.2 mmol), benzoyl chloride (4.2 mL, 36.2 mmol), 
and DMAP (4.42 g, 36.2 mmol) were successively added to a 
solution of alcohol S3 (5.13 g, 24.1 mmol) in CH2Cl2 (120 mL) 
at 0 °C. The mixture was stirred for 20 h at ambient temperature 
before the reaction was quenched with sat. aq. NH4Cl. The 
aqueous layer was extracted with tert-butyl methyl ether and the combined extracts were dried 
over MgSO4 and evaporated. The residue was purified by flash chromatography 
(hexanes/EtOAc, 95/5  90/10) to give product S4 as a colorless oil (6.77 g, 89 %). 1H NMR 
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(400 MHz, CDCl3):  = 8.03 (d, J = 7.1 Hz, 2H), 7.55 (tt, J = 7.5, 1.6 Hz, 1H), 7.43 (tt, J = 
7.5, 1.5 Hz, 2H), 5.52 (dddd, J = 7.5, 7.3, 5.8, 5.1 Hz, 1H), 2.70 (dd, J = 15.1, 7.3 Hz, 1H), 
2.62 (dd, J = 15.1, 5.8 Hz, 1H), 2.26 (tq, J = 7.3, 2.5 Hz, 2H), 2.03-1.90 (m, 2H), 1.71 (t, J = 
2.5, 3H), 1.38 ppm (s, 9H); 
13
C NMR (100 MHz, CDCl3):  = 169.3 (C), 165.7 (C), 132.9 
(CH), 130.2 (C), 129.6 (CH), 128.3 (CH), 81.0 (C), 77.7 (C), 76.2 (C), 70.6 (CH), 40.5 (CH2), 
33.4 (CH2), 27.9 (CH3), 15.0 (CH2), 3.7 ppm (CH3); IR (film): 2978, 2921, 1718, 1602, 1585, 
1451, 1392, 1367, 1314, 1270, 1217, 1150, 1109, 1069, 1041, 1025, 948, 842, 709, 687 cm
-1
; 
MS (EI): m/z (%): 261 (7), 260 (39), 259 (14), 243 (8), 174 (6), 138 (75), 123 (9), 121 (34), 
110 (8), 106 (8), 105 (100), 95 (10), 93 (30), 91 (8), 79 (11), 77 (34), 57 (34), 51 (5), 41 (9) ; 
HRMS (ESI): m/z: calcd for C19H24O4Na [M+Na]
+
: 339.1564; found 339.1567. 
Compound 35. Trifluoroacetic acid (9.8 mL, 132 mmol) was added to a solution of ester S4 
(6.98 g, 22 mmol) in CH2Cl2 (100 mL) at 0 °C. The mixture was 
stirred at ambient temperature for 10 h. H2O (80 mL) was then 
added, the aqueous layer was extracted with ethyl acetate, and the 
combined organic phases were dried over MgSO4 and evaporated. The residue was dissolved 
in a small amount of toluene and the solution was evaporated to remove residual 
trifluoroacetic acid by aceotropic distillation; this operation was repeated five times to give 
product 35 as an orange oil (5.78 g, quant.). 
1
H NMR (400 MHz, CDCl3):  = 10.54 (br s, 
1H), 8.02 (d, J = 7.1, 2H), 7.56 (tt, J = 7.4, 1.2 Hz, 1H), 7.43 (t, J = 7.4, 2H), 5.53 (ddt, J = 
5.8, 6.8, 6.3 Hz, 1H), 2.84 (dd, J = 15.9, 6.8 Hz, 1H), 2.77 (dd, J = 15.9, 5.8 Hz, 1H), 2.31-
2.25 (m, 2H), 2.06-1.93 (m, 2H), 1.71 ppm (t, J = 2.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): 
 = 176.2 (C), 165.8 (C), 133.0 (CH), 130.0 (C), 129.6 (CH), 128.3 (CH), 77.5 (C), 76.5 (C), 
70.0 (CH), 38.7 (CH2), 33.1 (CH2), 15.0 (CH2), 3.3 ppm (CH3); IR (film): 2922, 1790, 1712, 
1602, 1584, 1451, 1316, 1270, 1211, 1158, 1110, 1070, 1041, 1026, 935, 844, 805, 709, 685 
cm
-1
; MS (EI): m/z (%): 260 (5) [M]
+
, 259 (15), 199 (5), 174 (5), 139 (6), 138 (61), 123 (6), 
110 (6), 106 (8), 105 (100), 95 (13), 93 (29), 92 (5), 91 (11), 79 (10), 78 (5), 77 (46), 53 (6), 
51 (9); HRMS (ESI): m/z: calcd for C15H17O4 [M+H]
+
: 261.1127; found 261.1124. 
Compound 36. 2,4,6-Trichlorobenzoyl chloride (2.05 mL, 14.4 mmol) and triethylamine 
(1.85 mL, 14.4 mmol) were successively added to a 
solution of acid 35 (2.9 g, 11.3 mmol) in toluene (100 
mL) at 0 °C. The resulting mixture was stirred at this 
temperature for 20 min before a solution of alcohol 33 
(3.6 g, 10.3 mmol) was added, followed by DMAP 
(0.63 g, 5.0 mmol). The mixture was stirred at ambient 
temperature for 1 h 15 min before it was diluted with 
ethyl acetate and aq. citric acid solution (10 %). The organic layer was successively washed 
with brine, saturated NaHCO3 solution, and brine prior to drying over MgSO4 and 
evaporation. The residue was purified by flash chromatography (hexanes/EtOAc, 98/2  
95/5) to give ester 36 as a yellow oil (5.0 g, 82 %). 
1
H NMR (400 MHz, CDCl3):  = 8.01 (d, 
J = 7.4 Hz, 4 H, 2 dia.), 7.54 (t, J = 7.4 Hz, 2 H, 2 dia.), 7.46–7.37 (m, 4 H, 2 dia.), 5.59–5.50 
(m, 2 H, 2 dia.), 5.46 (dd, J = 10.2, 10.2 Hz, 1 H, 1 dia.), 5.44 (dd, J = 10.5, 10.5 Hz, 1 H, 1 
dia.), 5.31 (dq, J = 10.7, 2.2 Hz, 1 H, 1 dia.), 5.29 (dq, J = 10.6, 2.2 Hz, 1 H, 1 dia.), 5.25 (d, 
J = 10.1 Hz, 1 H, 1 dia.), 5.23 (d, J = 9.7 Hz, 1 H, 1 dia.), 5.03 (d, J = 9.0 Hz, 2 H, 2 dia.), 
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3.71–3.62 (m, 2 H, 2 dia.), 3.18–3.05 (m, 2 H, 2 dia.), 2.84 (dd, J = 15.3, 6.7 Hz, 2 H, 2 dia.), 
2.73 (dd, J = 15.4, 6.1 Hz, 2 H, 2 dia.), 2.38–2.30 (m, 2 H, 2 dia.), 2.30–2.22 (m, 4 H, 2 dia.), 
2.04–1.92 (m, 4 H, 2 dia., overlap), 1.96 (d, J = 2.0 Hz, 6 H, 2 dia., overlap), 1.70 (t, J = 2.5 
Hz, 6 H, 2 dia.), 1.59 (d, J = 1.2 Hz, 3 H, 1 dia.), 1.54 (d, J = 1.2 Hz, 3 H, 1 dia.), 0.98-0.90 
(m, 30 H, 2 dia.), 0.89 (d, J = 6.8 Hz, 3 H, 1 dia.), 0.84 (d, J = 6.8 Hz, 3 H, 1 dia.), 0.60–0.52 
ppm (m, 12 H, 2 dia.); 
13
C NMR (100 MHz, CDCl3):  = 169.2 (C), 169.1 (C), 165.8 (C), 
165.7 (C), 143.0 (CH, 2 dia.), 132.9 (CH, 2 dia.), 132.4 (CH), 132.4 (CH), 131.9 (C, 2 dia.), 
130.2 (C, 2 dia.), 129.6 (CH, 2 dia.), 128.3 (CH, 2 dia.), 109.6 (CH), 109.6 (CH), 90.0 (C, 2 
dia.), 83.1 (CH, 2 dia.), 77.6 (C, 2 dia.), 76.3 (C, 2 dia.), 76.1 (C, 2 dia.), 71.1 (CH), 71.1 
(CH), 70.5 (CH), 70.4 (CH), 39.3 (CH2), 39.3 (CH2), 39.2 (CH), 39.1 (CH), 36.9 (CH), 36.8 
(CH), 33.2 (CH2), 33.1 (CH2), 20.3 (CH3), 20.2 (CH3), 16.5 (CH3), 16.5 (CH3), 15.4 (CH3), 
15.3 (CH3), 15.0 (CH2), 15.0 (CH2), 12.1 (CH3), 12.1 (CH3), 6.9 (3 x CH3, 2 dia.), 5.0 (3 x 
CH2, 2 dia.), 4.3 (CH3, 2 dia.), 3.4 ppm (CH3, 2 dia.); IR (film): 3419, 2956, 2917, 2877, 
1789, 1721, 1452, 1370, 1315, 1266, 1212, 1173, 1111, 1071, 1017, 998, 910, 869, 733, 704 
cm
-1
; HRMS (ESI): m/z: calcd for C36H52O5SiNa [M + Na]
+
: 615.3476; found 615.3471. 
Compound 37. Activated molecular sieves (5 Å, ca. 20 g) were added to a solution of diyne 
36 (2.00 g, 3.4 mmol) in toluene (1.2 L) and the resulting 
suspension was heated to 80 °C before a solution of complex 21 
(0.22 g, 0.17 mmol) in toluene (10 mL) was introduced. The 
mixture was stirred at 80 °C for 3 h before it was allowed to reach 
ambient temperature. Insoluble materials were filtered off through 
a pad of silica which was carefully rinsed with ethyl acetate. The 
combined filtrates were evaporated and the residue purified by flash chromatography 
(hexanes/EtOAc, 1/0  95/5) to give cycloalkyne 37 as a yellow oil (1.56 g, 85 %). 1H NMR 
(400 MHz, CDCl3):  = 8.09 (d, J = 8.2 Hz, 2 H, 1 dia.), 8.02 (d, J = 8.2 Hz, 2 H, 1 dia.), 
7.59–7.51 (m, 2 H, 2 dia.), 7.48–7.39 (m, 4 H, 2 dia.), 5.73–5.66 (m, 1 H, 1 dia.), 5.60–5.51 
(m, 2 H, 2 dia., overlap), 5.55–5.47 (m, 2 H, 2 dia., overlap), 5.41–5.34 (m, 1 H, 1 dia., 
overlap), 5.34 (d, J = 9.8 Hz, 2 H, 2 dia., overlap), 5.23 (d, J = 3.5 Hz, 1 H, 1 dia.), 5.19 (d, 
J = 4.2 Hz, 1 H, 1 dia.), 3.79–3.71 (m, 2 H, 2 dia.), 3.37–3.26 (m, 2 H, 2 dia.), 3.17 (dd, J = 
17.3, 11.4 Hz, 1 H, 1 dia.), 3.10 (dd, J = 17.3, 3.4 Hz, 1 H, 1 dia.), 2.93 (dd, J = 17.2, 4.3 Hz, 
1 H, 1 dia.), 2.83 (dd, J = 17.3, 5.4 Hz, 1 H, 1 dia.), 2.70–2.54 (m, 2 H, 2 dia.), 2.52–2.31 (m, 
6 H, 2 dia.), 2.10–1.98 (m, 2 H, 2 dia.), 1.64 (d, J = 1.1 Hz, 3 H, 1 dia.), 1.62 (d, J = 1.1 Hz, 3 
H, 1 dia.), 1.06 (d, J = 6.2 Hz, 6 H, 2 dia.), 1.03 (d, J = 7.1 Hz, 3 H, 1 dia.), 1.00 (d, J = 6.8 
Hz, 3 H, 1 dia.), 0.99-0.91 (m, 24 H, 2 dia.), 0.62–0.54 ppm (m, 12 H, 2 dia.); 13C NMR (100 
MHz, CDCl3):  = 170.0 (C), 169.1 (C), 165.9 (C), 165.3 (C), 144.2 (CH), 144.0 (CH), 135.2 
(C, 2 dia.), 134.1 (CH), 133.7 (CH), 133.0 (CH), 133.0 (CH), 130.3 (C), 129.7 (CH), 129.5 
(CH), 129.4 (C), 128.4 (CH), 128.3 (CH), 110.8 (CH), 110.5 (CH), 93.8 (C), 93.1 (C), 83.0 
(CH), 82.2 (CH), 80.0 (C), 79.6 (C), 71.4 (CH, 2 dia.), 70.9 (CH), 70.7 (CH), 39.5 (CH2), 
39.5 (CH2), 37.5 (CH), 37.2 (CH), 37.0 (CH2, 2 dia.), 30.5 (CH2), 30.2 (CH2), 21.1 (CH3), 
21.0 (CH3), 17.3 (CH3), 17.1 (CH3), 16.2 (CH3), 16.2 (CH3), 16.1 (CH2), 14.5 (CH3), 14.4 
(CH3), 13.6 (CH2), 6.9 (3 x CH3, 2 dia.), 5.0 ppm (3 x CH2, 2 dia.); IR (film): 2959, 2933, 
2875, 1721, 1451, 1414, 1376, 1334, 1271, 1189, 1166, 1108, 1068, 1025, 963, 943, 880, 804, 
740, 709 cm
-1
; MS (EI): m/z (%): 494 (2), 416 (8), 282 (5), 207 (10), 160 (100), 159 (56), 131 
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(31), 115 (36), 105 (55), 87 (18), 59 (5); HRMS (ESI): m/z: calcd for C32H46O5SiNa [M + 
Na]
+
: 561.3007; found 561.3003. 
Compound 39. [Cp*Ru(MeCN)3]PF6 (38 mg, 0.074 mmol) and benzyldimethylsilane (0.47 
mL, 2.97 mmol) were successively added to a solution of cycloalkyne 
37 (400 mg, 0.74 mmol) in CH2Cl2 (1.5 mL) at 0 °C. The mixture was 
stirred at this temperature for 10 min until the catalyst had fully 
dissolved and then for 1 h at ambient temperature. Next, the solvent 
was slowly evaporated by a stream of Ar over ca. 30 min, at which 
point TLC control indicated complete conversion. The residue was purified by flash 
chromatography (hexanes/EtOAc, 98/2  95/5) to give product 38, which was directly used 
in the next step. 
A solution of anhydrous TBAF (1 M in THF, 3.0 mL, 3.0 mmol) was added at 0 °C to a 
solution of alkenylsilane 38 in THF (1.0 mL) and the resulting orange mixture stirred at 
ambient temperature for 2 h. For work up, the solution was filtered through a pad of silica 
which was carefully rinsed with ethyl acetate. The combined filtrates were evaporated and the 
residue purified by flash chromatography (hexanes/EtOAc, 90/10) to remove traces of the 
undesired (Z,Z)-diene isomer. Product 39 was thus obtained as a colorless oil (165 mg, 73 %). 
 20D  = −232.7 (c = 1, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 6.47 (ddd, J = 16.0, 10.4, 5.4 
Hz, 1H), 6.04 (dd, J = 10.8, 10.8 Hz, 1H), 5.74 (dd, J = 15.6, 10.6 Hz, 1H), 5.55 (d, J = 16.1 
Hz, 1H), 5.40 (ddd, J = 15.3, 8.8, 6.6 Hz, 1H), 5.35 (d, J = 4.5 Hz, 1H, overlap), 5.33 (d, J = 
9.5 Hz, 1H, overlap), 5.10 (dd, J = 10.9, 10.9 Hz, 1H), 3.60 (qd, J = 6.2, 6.2 Hz, 1H), 3.09 
(ddq, J = 11.7, 6.2, 5.8 Hz, 1H), 2.59-2.49 (m, 2H), 2.44 (dqd, J = 9.4, 6.5, 3.7 Hz, 1H), 2.01-
1.84 (m, 2H), 1.72 (d, J = 1.2 Hz, 3H), 1.55 (br s, 1H), 1.18 (d, J = 6.1 Hz, 3H), 0.99 (d, J = 
6.7 Hz, 3H), 0.94 ppm (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 166.7 (C), 146.4 
(CH), 134.5 (CH), 133.1 (CH), 131.9 (C), 131.7 (CH), 128.9 (CH), 128.3 (CH), 127.7 (CH), 
83.3 (CH), 71.5 (CH), 40.0 (CH), 35.7 (CH), 32.2 (CH2), 31.1 (CH2), 20.3 (CH3), 17.5 (CH3), 
16.4 (CH3), 14.9 ppm (CH3); IR (film): 3453, 2964, 2928, 2872, 1709, 1641, 1451, 1376, 
1336, 1313, 1259, 1190, 1141, 1085, 1005, 957, 923, 848, 800, 736, 691 cm
-1
; MS (EI): m/z 
(%): 304 (2) [M+], 162 (7), 94 (100), 79 (41), 68 (12), 55 (4), 41 (9); HRMS (ESI): m/z: calcd 
for C19H28O3Na [M + Na]
+
: 327.1931; found 327.1931. 
Compound 19. Oxalyl chloride (88 μL, 1.02 mmol) was added to a solution of DMSO (0.14 
mL, 2.0 mmol) in CH2Cl2 (5 mL) at –78 °C before a solution of 
alcohol 39 (62 mg, 0.20 mmol) in CH2Cl2 (3 mL) was added. After 1 
h at this temperature, triethylamine (0.42 mL, 3.1 mmol) was 
introduced and stirring continued for 30 min at this temperature and 
for 1.5 h at 0 °C. The reaction was quenched with sat. aq. NH4Cl, the 
aqueous phase was extracted with CH2Cl2, and the combined organic 
layers were dried over MgSO4 and evaporated. The residue was purified by flash 
chromatography (hexanes/EtOAc, 90/10) to furnish product 19 as a pale yellow solid (51 mg, 
82 %).  20D = −3.9 (c = 1, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 6.48 (ddd, J = 16.0, 
10.4, 5.4 Hz, 1H), 6.05 (dd, J = 10.8, 10.8 Hz, 1H), 5.73 (dd, J = 15.6, 10.7 Hz, 1H), 5.55 (d, 
J = 16.1 Hz, 1H), 5.41 (ddd, J = 15.6, 8.9, 6.5 Hz, 1H, overlap), 5.39-5.31 (m, 2H, overlap), 
5.08 (dd, J = 10.9, 10.9 Hz, 1H), 3.43 (dq, J = 9.4, 6.9 Hz, 1H), 3.10 (dqd, J = 11.7, 6.4, 3.2 
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Hz, 1H), 2.60-2.46 (m, 2H), 2.14 (s, 3H), 2.02-1.85 (m, 2H), 1.78 (d, J = 1.3 Hz, 3H), 1.17 (d, 
J = 6.8 Hz, 3H), 0.92 ppm (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 209.0 (C), 
166.5 (C), 146.6 (CH), 134.5 (CH), 133.3 (C), 131.4 (CH), 129.8 (CH), 129.1 (CH), 128.2 
(CH), 127.8 (CH), 82.6 (CH), 46.8 (CH), 36.0 (CH), 32.2 (CH2), 31.2 (CH2), 27.9 (CH3), 17.3 
(CH3), 16.1 (CH3), 14.9 ppm (CH3); IR (film): 2965, 2931, 2872, 1713, 1642, 1453, 1373, 
1353, 1313, 1244, 1188, 1140, 1088, 1001, 957, 872, 848, 829, 799, 768, 733, 701 cm
-1
; MS 
(EI): m/z (%): 302 (1) [M+], 162 (8), 94 (100), 79 (42), 68 (12), 53 (2), 43 (11); HRMS (ESI): 
m/z: calcd for C19H26O3Na [M + Na]
+
: 325.1774; found 327.1775. 
Lactimidomycin (1). Me3SiCl (0.80 mL, 6.20 mmol) and triethylamine (0.86 mL, 6.20 
mmol) were added to a solution of ketone 39 (186 
mg, 0.61 mmol) in THF (15 mL) at –78 °C. Next, 
LiHMDS (1 M in THF, 1.23 mL, 1.23 mmol) was 
slowly introduced and the resulting mixture stirred at 
–78 °C for 1 h. The reaction was then quenched with 
pH 7 phosphate buffer and the product extracted with 
CH2Cl2 (3 x 10 mL). The combined organic phases were dried over MgSO4 and evaporated to 
give the corresponding silyl enol ether 40, which was immediately used in the next step 
without further purification. 
Molecular sieves (4 Å, ca. 1.5 g) and aldehyde 41b (97 mg, 0.61 mmol) were added to a 
solution of the crude silyl enol ether in propionitrile (10 mL). The mixture was cooled to        
–78 °C before a solution of compound 42 [prepared upon stirring of a solution of PhBCl2 (94 
µL, 0.70 mmol) and N-tosyl-D-tryptophane (245 mg, 0.70 mmol) in CH2Cl2 (4.5 mL) for 1 h, 
followed by removal of the solvent]
3
 in propionitrile (4.5 mL) was added dropwise. After 
stirring for 35 h at –78 °C, the reaction was quenched with sat. aq. NaHCO3 (15 mL), the 
aqueous phase was extracted with CH2Cl2 (3 x 20 mL), and the combined organic layers were 
dried over MgSO4 and evaporated. The resulting crude product was dissolved in THF (100 
mL) at 0 °C and treated with 11.0 mL of buffered HF∙pyridine solution [prepared from THF 
(7.98 mL), pyridine (2.96 mL) and HF∙pyridine complex (0.65 mL, 70 % w/w)]. The mixture 
was stirred at 0 °C for 2 h and warmed to ambient temperature for 30 min to complete the 
desilylation. Dilution with CH2Cl2 (100 mL), washing of the organic layer with sat. aq. 
NaHCO3 (50 mL) and aq. CuSO4 solution (1 M, 3 x 50 mL), drying over MgSO4 and 
evaporation of the solvents left a residue, which was purified by flash chromatography 
(EtOAc/hexanes, 50/50  100/0) to give product 1 as a white solid (138 mg, 50 %).  20D = 
+6.9 (c = 0.5, DMSO);
4
  20D = −7.0 (c = 0.5, CHCl3); 
1
H NMR (600 MHz, CDCl3): see Table 
S-1; 
13
C NMR (150 MHz, CDCl3): see Table S-2; IR (film): 3481, 3239, 2925, 2852, 1695, 
1453, 1376, 1259, 1190, 1145, 1084, 1003, 829, 796, 767, 733, 701 cm
-1
; HRMS (ESI): m/z: 
calcd for C26H35NO6Na [M + Na]
+
: 480.2357; found 480.2363. 
                                                 
3
  K. Ishihara, S. Kondo, H. Yamamoto, J. Org. Chem. 2000, 65, 9125-9128. 
4
  The original isolation paper reports:  20D  = −20 (c = 0.5, DMSO), cf. K. Sugawara, Y. Nishiyama, 
S. Toda, N. Komiyama, M. Hatori, T. Moriyama, Y. Sawada, H. Kamei, M. Konishi, T. Oki, J. 
Antibiot. 1992, 45, 1433-1441. It seems, however, that this value is incorrect. Prof. B. Shen, 
University of Wisconsin, kindly informed us that the optical rotation of authentic lactimidomycin 




Table S-1. Comparison of the recorded 
1
H NMR data (CDCl3) of lactimidomycin (1) with 
those reported in the literature;
5





Literature (500 MHz) 
δ (ppm) mult. (J in Hz) 
Experimental (600 MHz) 
























5.53 d (16.0) 
6.49 ddd (16.0, 10.0, 5.0) 
1.96 m/2.56 m 
1.96 m/2.54 m 
5.42 m 
5.72 dd (15.5, 10.5) 
6.06 t (11.0) 
5.06 t (11.0) 
3.11 m 





1.33 ddd (14.0, 9.0, 3.0) 
1.60 ddd (14.0, 10.5, 4.5) 
2.48 m 
2.34 m/2.76 m 
0.92 d (6.5) 
1.78 d (1.5) 
1.19 d (7.0) 
2.32 m/2.80 m 
7.98 br s 
5.54 d (16.1) 
6.47 ddd (16.1, 10.2, 5.2) 
1.95 m/2.56 m 
1.92 m/2.52 m 
5.41 ddd (15.6, 9.1, 6.2) 
5.71 dd (15.6, 10.7) 
6.05 t (10.8) 
5.05 t (10.9) 
3.10 m 
5.34 m  
5.34 m 
3.42 dq (9.7, 6.8) 
2.58 m 
4.11 m 
1.32 ddd (14.0, 8.9, 2.8) 
1.60 ddd (14.1, 10.5, 4.9) 
2.49 m 
2.34 m/2.76 m 
0.91 d (6.8) 
1.77 d (1.3) 
1.18 d (6.8) 
2.32 m/2.78 m 

























                                                 
5
  J. Ju, J.-W. Seo, Y. Her, S.-K. Lim, B. Shen, Org. Lett. 2007, 9, 5183-5186. 
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Table S-2. Comparison of the recorded 
13
C NMR data (δ in ppm, CDCl3) of lactimidomycin 















































































































15-epi-Lactimidomycin (15-epi-1). Prepared analogously using ent-42 [prepared upon 
stirring of a solution of PhBCl2 (11 µL, 0.083 mmol) 
and N-tosyl-L-tryptophane (30 mg, 0.083 mmol) in 
CH2Cl2 (1 mL) for 1 h, followed by removal of the 
solvent]
3
 as promoter for the Mukaiyama aldol 
reaction. White solid (7 mg, 18 %, dr 85/15). 
1
H 
NMR (600 MHz, CDCl3):  = 7.92 (br s, 1H), 6.48 
(ddd, J = 16.0, 10.4, 5.4 Hz, 1H), 6.05 (dd, J = 10.8, 10.8 Hz, 1H), 5.71 (dd, J = 15.6, 10.7 
Hz, 1H), 5.54 (d, J = 16.1 Hz, 1H), 5.42 (ddd, J = 15.4, 9.2, 6.2 Hz, 1H), 5.36-5.32 (m, 2H, 
overlap), 5.04 (dd, J = 10.9, 10.9 Hz, 1H), 4.13-4.08 (m, 1H), 3.42 (dq, J = 9.9, 6.7 Hz, 1H), 
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3.14-3.06 (m, 1H), 2.81-2.72 (m, 2H), 2.66-2.62 (m, 2H), 2.59-2.54 (m, 1H), 2.54-2.46 (m, 
2H), 2.37-2.27 (m, 2H), 2.02-1.85 (m, 2H), 1.77 (d, J = 1.3 Hz, 3H), 1.61 (ddd, J = 14.1, 10.6, 
4.9 Hz, 1H), 1.31 (ddd, J = 14.0, 8.9, 2.8 Hz, 1H), 1.18 (d, J = 6.8 Hz, 3H), 0.91 ppm (d, J = 
6.8 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  = 212.5 (C), 172.2 (C), 172.0 (C), 166.7 (C), 
147.0 (CH), 134.5 (CH), 134.0 (C), 131.2 (CH), 129.5 (CH), 129.0 (CH), 128.2 (CH), 128.2 
(CH), 82.4 (CH), 64.9 (CH), 47.4 (CH2), 46.8 (CH), 40.8 (CH2), 38.5 (CH2), 37.2 (CH2), 36.0 
(CH), 32.4 (CH2), 31.3 (CH2), 27.2 (CH), 17.6 (CH3), 16.2 (CH3), 15.4 ppm (CH3); IR (film): 
3422, 2929, 2856, 1698, 1454, 1376, 1265, 1190, 1143, 1087, 1024, 829, 795, 766, 734, 702 
cm
-1
; HRMS (ESI): m/z: calcd for C26H35NO6Na [M + Na]
+
: 480.2357; found 480.2358. 
 
Compound 66. A solution of buffered NaOCl (0.55 M, 50 mL) was prepared by mixing 14 
mL of commercial bleach
6
 and Na2HPO4 (36 mL, 0.05 M in 
water). This solution was cooled to 4 °C before a solution of 
enyne 37 (2.1 g, 3.9 mmol) and (R,R)-(–)-[1,2-cyclohexane-
diamino-N,N’-bis(3,5-di-tert-butylsalicylidene] manganese 
chloride (0.5 g, 0.78 mmol) in CH2Cl2 (25 mL) was added. The 
resulting biphasic mixture was vigorously stirred at 4 °C for 
20 h. It was then diluted with tert-butyl methyl ether and brine, the aqueous phase was 
extracted with tert-butyl methyl ether, and the combined extracts were dried over MgSO4 and 
evaporated. The residue was purified by flash chromatography (hexanes/EtOAc, 95/5  
90/10) to give epoxide 66 as a yellow oil (1.36 g, 63 %). The two diastereomers (at C3) are 
separable by flash chromatography (hexanes/EtOAc, 95/5). First diastereomer: 
1
H NMR (400 
MHz, CDCl3):  = 8.01 (d, J = 8.4 Hz, 2H), 7.57 (tt, J = 7.5, 1.3 Hz, 1H), 7.44 (t, J = 7.7 Hz, 
2H), 5.65 (dddd, J = 11.5, 4.6, 4.6, 2.6 Hz, 1H), 5.43 (d, J = 9.7 Hz, 1H), 5.24 (d, J = 3.5 Hz, 
1H), 3.75 (qd, J = 6.1, 3.5 Hz, 1H), 3.52–3.49 (m, 1H), 3.15 (dd, J = 17.0, 11.4 Hz, 1H), 2.97 
(dd, J = 17.1, 4.6 Hz, 1H), 2.88 (dd, J = 9.9, 3.8 Hz, 1H), 2.56 (dd, J = 17.7, 11.6 Hz, 1H), 
2.48–2.37 (m, 2H), 2.31–2.20 (m, 1H), 2.13 (ddq, J = 10.5, 6.8, 3.5 Hz, 1H), 2.04–1.94 (m, 
1H), 1.73 (d, J = 1.2 Hz, 3H), 1.17 (d, J = 7.1 Hz, 3H), 1.07 (d, J = 6.3 Hz, 3H), 1.00-0.92 (m, 
12H), 0.58 ppm (q, J = 7.8 Hz, 6H); 
13
C NMR (100 MHz, CDCl3):  = 169.7 (C), 165.4 (C), 
134.4 (CH), 133.3 (CH), 130.4 (C), 129.7 (CH), 128.6 (CH), 128.5 (C), 86.8 (C), 81.0 (CH), 
77.5 (C), 71.6 (CH), 70.5 (CH), 60.3 (CH), 46.5 (CH), 39.8 (CH), 38.6 (CH), 37.3 (CH2), 
30.1 (CH2), 21.5 (CH3), 16.6 (CH3), 15.3 (CH3), 14.8 (CH3), 13.0 (CH2), 7.1 (3 x CH3), 5.2 
ppm (3 x CH2).  
Second diastereomer: 
1
H NMR (400 MHz, CDCl3):  = 8.07 (d, J = 8.5 Hz, 2H), 7.55 (t, J = 
7.5 Hz, 1H), 7.43 (t, J = 7.7 Hz, 2H), 5.46–5.37 (m, 1H, overlap), 5.43 (d, J = 10.1 Hz, 1H, 
overlap), 5.25 (d, J = 3.0 Hz, 1H), 3.76 (qd, J = 6.1, 3.4 Hz, 1H), 3.54–3.51 (m, 1H), 3.08 
(dd, J = 17.2, 3.2 Hz, 1H), 2.97 (dd, J = 17.1, 4.6 Hz, 1H), 2.88–2.80 (m, 2H), 2.57–2.49 (m, 
1H), 2.43 (ddq, J = 10.0, 6.5, 3.3 Hz, 1H), 2.30–2.21 (m, 2H), 2.13 (dqd, J = 10.5, 6.8, 3.3 
Hz, 1H), 2.05–1.97 (m, 1H), 1.75 (d, J = 1.2 Hz, 3H), 1.20 (d, J = 7.1 Hz, 3H), 1.06 (d, J = 
6.2 Hz, 3H), 1.00-0.92 (m, 12H), 0.58 ppm (q, J = 7.8 Hz, 6H); 
13
C NMR (100 MHz, CDCl3): 
 = 168.7 (C), 166.0 (C), 134.0 (CH), 133.3 (CH), 130.4 (C), 129.9 (CH), 128.8 (C), 128.5 
                                                 
6
 From Fisher Scientific UK. Ref. S/5042/15 - Sodium hypochlorite min 14 % available chlorine 
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(CH), 85.7 (C), 81.3 (CH), 77.4 (C), 71.6 (CH), 70.7 (CH), 60.4 (CH), 46.6 (CH), 39.8 (CH), 
38.9 (CH), 37.9 (CH2), 30.5 (CH2), 21.5 (CH3), 16.6 (CH3), 15.6 (2 x CH3), 14.7 (CH2), 7.1 (3 
x CH3), 5.2 ppm (3 x CH2); IR (film): 2958, 2931, 2875, 1720, 1451, 1376, 1313, 1271, 1170, 
1108, 1068, 1016, 949, 878, 836, 710 cm
-1
; MS (EI): m/z (%): 510 (6), 304 (2), 207 (15), 159 
(100), 131 (46), 115 (46), 105 (39), 87 (17); HRMS (ESI): m/z: calcd for C32H46O6SiNa [M + 
Na]
+
: 577.2956; found 577.2951. 
Compound 67. p-Toluenesulfonic acid (0.23 g, 1.23 mmol) was added to a solution of 
epoxide 66 (1.36 g, 2.45 mmol) in MeOH (50 mL) and the 
resulting mixture was stirred at 60 °C for 6 h. The methanol was 
evaporated and the residue purified by flash chromatography 
(hexanes/EtOAc, 9/1  6/4) to give diol 67 as a white solid 
(0.85 g, 73 %). 
1
H NMR (400 MHz, CDCl3):  = 8.03 (d, J = 
8.4 Hz, 2 H, 1 dia.), 8.00 (d, J = 8.3 Hz, 2 H, 1 dia.), 7.60–7.54 
(m, 2 H, 2 dia.), 7.48–7.41 (m, 4 H, 2 dia.), 5.70 (dddd, J = 11.1, 8.6, 2.6, 2.6 Hz, 1 H, 1 
dia.), 5.59 (dddd, J = 10.5, 5.2, 5.2, 2.8 Hz, 1 H, 1 dia.), 5.27 (d, J = 2.5 Hz, 1 H, 1 dia.), 
5.18–5.12 (m, 1 H, 1 dia., overlap), 5.18–5.12 (m, 2 H, 2 dia., overlap), 4.17 (d, J = 9.3 Hz, 1 
H, 1 dia.), 3.97 (dd, J = 9.9, 2.3 Hz, 1 H, 1 dia.), 3.67–3.59 (m, 2 H, 2 dia.), 3.48–3.36 (m, 2 
H, 2 dia., overlap), 3.45 (s, 3 H, 1 dia., overlap), 3.41 (s, 3 H, 1 dia., overlap), 3.14–2.96 (m, 2 
H, 2 dia.), 2.58–2.45 (m, 4 H, 2 dia.), 2.45–2.33 (m, 4 H, 2 dia.), 2.33–2.22 (m, 4 H, 2 dia.), 
2.13–1.99 (m, 2 H, 2 dia.), 1.91 (d, J = 1.0 Hz, 3 H, 1 dia.), 1.80 (d, J = 1.1 Hz, 3 H, 1 dia.), 
1.19 (d, J = 6.3 Hz, 3 H, 1 dia.), 1.18 (d, J = 6.2 Hz, 3 H, 1 dia.), 0.96 (d, J = 7.2 Hz, 3 H, 1 
dia., overlap), 0.95 (d, J = 6.6 Hz, 3 H, 1 dia., overlap), 0.95 ppm (d, J = 6.0 Hz, 3 H, 1 dia., 
overlap); 
13
C NMR (100 MHz, CDCl3):  = 169.6 (C), 168.8 (C), 166.1 (C), 165.4 (C), 133.3 
(CH), 133.3 (CH), 133.1 (C), 132.5 (C), 131.6 (CH), 131.3 (CH), 130.3 (C), 130.1 (C), 129.7 
(CH), 129.7 (CH), 128.6 (CH), 128.6 (CH), 88.2 (C), 87.7 (C), 80.6 (CH), 79.0 (CH), 77.4 
(C), 77.3 (C), 74.5 (CH), 73.6 (CH), 72.5 (CH), 72.1 (CH), 71.8 (CH), 71.2 (CH), 70.8 (CH), 
70.2 (CH), 57.1 (CH3), 57.0 (CH3), 40.9 (CH), 40.8 (CH2), 40.6 (CH), 39.8 (CH), 38.1 (CH), 
37.0 (CH2), 33.3 (CH2), 30.5 (CH2), 20.2 (CH3), 20.1 (CH3), 16.9 (CH3), 16.8 (CH3), 16.0 
(CH2), 14.0 (CH3), 13.8 (CH3), 12.9 (CH2), 10.9 ppm (CH3, 2 dia.); IR (film): 3495, 2968, 
2930, 2875, 1719, 1450, 1377, 1315, 1270, 1191, 1174, 1105, 1070, 1049, 1025, 984, 940, 
881, 850, 735, 711 cm
-1




Compound 68. Dess-Martin periodinane (2.3 g, 5.4 mmol) was added to a solution of diol 67 
(850 mg, 1.8 mmol) in CH2Cl2 (50 mL) at 0 °C. The mixture 
was stirred at this temperature for 4 h before the reaction was 
quenched with a few drops of EtOH. The solvents were 
evaporated and the residue was purified by flash 
chromatography (hexanes/EtOAc, 9/1  7/3), affording ketone 
68 as a white solid (740 mg, 87 %). 
1
H NMR (400 MHz, 
CDCl3):  = 8.03 (d, J = 8.2 Hz, 2 H, 1 dia.), 8.00 (d, J = 8.5 Hz, 2 H, 1 dia.), 7.59–7.53 (m, 2 
H, 2 dia.), 7.47–7.40 (m, 4 H, 2 dia.), 5.68 (dddd, J = 10.7, 7.6, 3.2, 3.2 Hz, 1 H, 1 dia.), 5.58 
(dddd, J = 10.5, 5.2, 5.2, 2.7 Hz, 1 H, 1 dia.), 5.28 (d, J = 8.6 Hz, 1 H, 1 dia.), 5.26 (d, J = 7.3 
Hz, 1 H, 1 dia.), 5.23 (d, J = 3.6 Hz, 1 H, 1 dia.), 5.16 (d, J = 4.2 Hz, 1 H, 1 dia.), 4.15 (d, J = 
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8.8 Hz, 1 H, 1 dia.), 3.97 (dd, J = 9.8, 2.5 Hz, 1 H, 1 dia.), 3.61 (d, J = 9.8 Hz, 1 H, 1 dia., 
overlap), 3.61 (d, J = 9.8 Hz, 1 H, 1 dia., overlap), 3.48–3.38 (m, 2 H, 2 dia., overlap), 3.46 
(s, 3 H, 1 dia., overlap), 3.43 (s, 3 H, 1 dia., overlap), 3.12–2.98 (m, 2 H, 2 dia.), 2.60–2.45 
(m, 4 H, 2 dia.), 2.45–2.33 (m, 2 H, 2 dia.), 2.33–2.21 (m, 2 H, 2 dia.), 2.13 (s, 3 H, 1 dia.), 
2.11 (s, 3 H, 1 dia.), 2.08–1.95 (m, 2 H, 2 dia.), 1.92 (d, J = 1.0 Hz, 3 H, 1 dia.), 1.85 (d, J = 
1.1 Hz, 3 H, 1 dia.), 1.14 (d, J = 6.8 Hz, 3 H, 1 dia., overlap), 1.13 (d, J = 6.8 Hz, 3 H, 1 dia., 
overlap), 0.94 (d, J = 7.3 Hz, 3 H, 1 dia.), 0.92 ppm (d, J = 7.3 Hz, 3 H, 1 dia.); 
13
C NMR 
(100 MHz, CDCl3):  = 209.6 (C), 209.5 (C), 169.4 (C), 168.5 (C), 166.0 (C), 165.4 (C), 
134.1 (C), 133.7 (C), 133.3 (CH), 133.3 (CH), 130.2 (C), 130.1 (C), 129.7 (CH), 129.7 (CH), 
128.5 (CH, 2 dia.), 128.5 (CH), 128.3 (CH), 88.1 (C), 87.3 (C), 80.8 (CH), 80.5 (CH), 77.4 
(C, 2 dia.), 74.5 (CH), 74.0 (CH), 71.3 (CH), 70.7 (CH), 70.6 (CH), 70.3 (CH), 57.0 (CH3), 
57.0 (CH3), 46.8 (CH), 46.8 (CH), 40.4 (CH2), 39.4 (CH), 38.0 (CH), 37.1 (CH2), 32.9 (CH2), 
30.6 (CH2), 28.1 (CH3, 2 dia.), 16.1 (CH3), 15.9 (CH3), 15.9 (CH2), 13.5 (CH3), 13.4 (CH3), 
13.0 (CH2), 10.8 ppm (CH3, 2 dia.); IR (film): 3551, 2968, 2931, 2875, 1713, 1450, 1354, 
1314, 1271, 1190, 1170, 1104, 1070, 1049, 1025, 983, 942, 884, 850, 711 cm
-1
; MS (EI): m/z 
(%): 470 (<1) [M]
+
, 399 (3), 289 (38), 239 (12), 204 (7), 181 (14), 167 (25), 121 (13), 109 
(29), 105 (100), 77 (21), 43 (21); HRMS (ESI): m/z: calcd for C27H34O7Na [M + Na]
+
: 
493.2197; found 493.2195. 
Compound 69: Triphenylstannane (1.68 g, 4.8 mmol) and AIBN (158 mg, 1.0 mmol) were 
added to a carefully degassed solution of alkyne 68 (450 mg, 1.0 mmol) in toluene (13 mL) 
and the resulting mixture was stirred at 80 °C for 3 h. The mixture was concentrated under 
vacuum and the residue purified by flash chromatography 
(hexanes/EtOAc, 9/1  7/3) to give the corresponding 
alkenylstannane as a white solid.  
Iodine (295 mg, 1.2 mmol) was added to a solution of this 
compound in CH2Cl2 (25 mL) at 0 °C. The resulting mixture 
was warmed to ambient temperature for 1 h before the solvent 
was evaporated and the residue purified by flash chromatography (hexanes/EtOAc, 8/2  
7/3) to furnish the two diastereomers of iodoalkene 69. The fast eluting diastereomer (71 mg, 
12 %) and the slow eluting one (186 mg, 33 %) were both obtained as white solids. First 
diastereomer:  20D = +86.0 (c = 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 8.05 (d, J = 
8.5 Hz, 2H), 7.58 (tt, J = 7.4, 1.5 Hz, 1H), 7.45 (t, J = 7.6 Hz, 2H), 6.49 (t, J = 7.6 Hz, 1H), 
5.54–5.45 (m, 1H), 5.23 (d, J = 9.6 Hz, 1H), 5.20 (d, J = 3.5 Hz, 1H), 3.97 (d, J = 9.0 Hz, 
1H), 3.72 (d, J = 9.0 Hz, 1H), 3.46–3.37 (m, 1H, overlap), 3.38 (s, 3H, overlap), 2.95 (dd, J = 
14.4, 3.3 Hz, 1H), 2.73 (s, 1H), 2.55 (dd, J = 14.4, 10.6 Hz, 1H), 2.41–2.22 (m, 2H), 2.17–
2.09 (m, 1H, overlap), 2.14 (s, 3H, overlap), 2.09–1.99 (m, 1H), 1.90 (d, J = 1.3 Hz, 3H), 
1.86–1.72 (m, 1H), 1.13 (d, J = 6.6 Hz, 3H), 0.97 ppm (d, J = 7.3 Hz, 3H); 13C NMR (100 
MHz, CDCl3):  = 209.6 (C), 168.1 (C), 166.3 (C), 138.5 (CH), 134.0 (C), 133.4 (CH), 130.1 
(C), 129.8 (CH), 128.6 (CH), 128.1 (CH), 90.0 (CH), 81.0 (CH), 73.9 (CH), 69.5 (CH), 56.9 
(CH3), 46.8 (CH), 40.6 (CH2), 39.0 (CH), 33.3 (CH2), 30.7 (CH2), 28.1 (CH3), 15.9 (CH3), 
13.4 (CH3), 10.8 ppm (CH3); IR (film): 3515, 2969, 2936, 2875, 1725, 1703, 1449, 1356, 
1314, 1248, 1190, 1172, 1146, 1095, 1064, 1043, 1025, 977, 905, 874, 845, 714 cm
-1
; MS 
(EI): m/z (%): 527 (5), 471 (2), 429 (7), 295 (17), 210 (11), 181 (27), 169 (13), 151 (55), 121 
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(23), 109 (61), 105 (100), 77 (29), 43 (45); HRMS (ESI): m/z: calcd for C27H35O7INa [M + 
Na]
+
: 621.1320; found 621.1321.  
Second diastereomer:  20D = +62.5 (c = 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 8.03 
(d, J = 8.5 Hz, 2H), 7.56 (tt, J = 7.5, 1.4 Hz, 1H), 7.44 (t, J = 7.6 Hz, 2H), 5.96 (dd, J = 9.1, 
5.1 Hz, 1H), 5.57–5.50 (m, 1H), 5.29 (d, J = 9.9 Hz, 1H), 5.09 (d, J = 3.8 Hz, 1H), 3.86 (d, 
J = 9.1 Hz, 1H), 3.41 (qd, J = 9.6, 6.8 Hz, 1H), 3.34 (s, 3H), 3.13 (d, J = 9.1 Hz, 1H), 2.97 
(dd, J = 17.6, 4.9 Hz, 1H), 2.87 (dd, J = 17.7, 11.1 Hz, 1H), 2.70 (s, 1H), 2.38–2.21 (m, 2H), 
2.17–2.08 (m, 1H, overlap), 2.11 (s, 3H, overlap), 2.08–2.01 (m, 2H), 1.85 (d, J = 1.3 Hz, 
3H), 1.13 (d, J = 6.8 Hz, 3H), 0.95 ppm (d, J = 7.3 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): 
 = 209.4 (C), 169.0 (C), 165.4 (C), 140.7 (CH), 133.4 (C), 133.2 (CH), 130.3 (C), 129.7 
(CH), 128.5 (CH), 128.5 (CH), 88.7 (CH), 80.9 (CH), 70.2 (CH), 69.4 (CH), 56.7 (CH3), 46.7 
(CH), 38.3 (CH), 36.7 (CH2), 30.0 (CH2), 29.6 (CH2), 28.1 (CH3), 16.0 (CH3), 13.8 (CH3), 
10.9 ppm (CH3); IR (film): 3511, 2969, 2928, 2875, 1713, 1450, 1353, 1314, 1270, 1191, 
1169, 1105, 1067, 1025, 981, 936, 852, 711 cm
-1
; MS (EI): m/z (%): 527 (2), 471 (2), 429 (7), 
295 (17), 210 (9), 181 (31), 169 (13), 151 (58), 121 (24), 109 (65), 105 (100), 77 (29), 43 
(46); HRMS (ESI): m/z: calcd for C27H35O7INa [M + Na]
+
: 621.1320; found 621.1324. 
Compound 70. Triphenylstannane (434 mg, 1.24 mmol) and AIBN (51 mg, 0.31 mmol) were 
added to a carefully degassed solution of iodoalkene 69 (370 
mg, 0.62 mmol) in toluene (15 mL) and the resulting mixture 
was stirred at 70 °C for 2 h. The solvents were evaporated and 
the residue purified by flash chromatography (hexanes/EtOAc, 
9/1  7/3) to give macrolactone 70 (300 mg, quant.) as a 
colorless oil. 
1
H NMR (400 MHz, CDCl3):  = 8.04 (d, J = 8.6 
Hz, 2 H, 1 dia.), 8.01 (d, J = 8.3 Hz, 2 H, 1 dia.), 7.59–7.53 (m, 2 H, 2 dia.), 7.47–7.39 (m, 4 
H, 2 dia.), 5.80–5.67 (m, 2 H, 2 dia.), 5.56–5.49 (m, 2 H, 2 dia.), 5.47 (dd, J = 16.2, 7.0 Hz, 1 
H, 1 dia.), 5.36 (dd, J = 15.9, 7.3 Hz, 1 H, 1 dia.), 5.25 (d, J = 9.6 Hz, 1 H, 1 dia.), 5.23 (d, 
J = 9.6 Hz, 1 H, 1 dia.), 5.16 (d, J = 3.3 Hz, 1 H, 1 dia.), 5.02 (d, J = 3.8 Hz, 1 H, 1 dia.), 3.79 
(dd, J = 9.3, 0.9 Hz, 1 H, 1 dia.), 3.69 (dd, J = 9.5, 3.2 Hz, 1 H, 1 dia.), 3.46–3.35 (m, 2 H, 2 
dia.), 3.31 (s, 3 H, 1 dia.), 3.30 (s, 3 H, 1 dia.), 3.28–3.21 (m, 2 H, 2 dia.), 3.00 (s, 1 H, 1 
dia.), 2.96 (s, 1 H, 1 dia.), 2.93 (dd, J = 17.3, 4.2 Hz, 1 H, 1 dia.), 2.87 (dd, J = 13.1, 3.0 Hz, 
1 H, 1 dia.), 2.71 (dd, J = 17.2, 11.4 Hz, 1 H, 1 dia.), 2.54 (dd, J = 13.1, 10.6 Hz, 1 H, 1 dia.), 
2.49–2.37 (m, 1 H, 1 dia.), 2.35–2.14 (m, 3 H, 2 dia.), 2.14–1.93 (m, 4 H, 2 dia., overlap), 
2.14–1.93 (m, 1 H, 1 dia., overlap), 2.13 (s, 3 H, 1 dia., overlap), 2.10 (s, 3 H, 1 dia., overlap), 
1.90 (d, J = 1.3 Hz, 3 H, 1 dia.), 1.81 (d, J = 1.3 Hz, 3 H, 1 dia.), 1.75–1.60 (m, 1 H, 1 dia.), 
1.12 (d, J = 6.8 Hz, 6 H, 2 dia.), 0.95 (d, J = 7.1 Hz, 3 H, 1 dia.), 0.93 ppm (d, J = 7.1 Hz, 3 
H, 1 dia.); 
13
C NMR (100 MHz, CDCl3):  = 209.7 (C), 209.5 (C), 169.2 (C), 168.7 (C), 166.1 
(C), 165.5 (C), 136.5 (CH), 136.4 (CH), 134.1 (C), 133.7 (C), 133.3 (CH), 133.2 (CH), 131.7 
(CH), 130.4 (C), 130.2 (C), 129.7 (CH), 129.6 (CH), 128.8 (CH), 128.5 (CH), 128.5 (CH), 
128.0 (CH, 2 dia.), 83.4 (CH), 82.6 (CH), 80.7 (CH), 80.5 (CH), 71.3 (CH, 2 dia.), 71.1 (CH), 
69.7 (CH), 56.7 (CH3), 56.5 (CH3), 46.8 (CH), 46.7 (CH), 40.9 (CH2), 38.4 (CH), 37.5 (CH), 
37.4 (CH2), 33.4 (CH2), 30.2 (CH2), 28.2 (CH3), 28.1 (CH3), 27.2 (CH2), 26.4 (CH2), 16.1 
(CH3), 15.9 (CH3), 13.7 (CH3), 13.5 (CH3), 11.2 (CH3), 11.0 ppm (CH3); IR (film): 3524, 





; MS (EI): m/z (%): 472 (<1) [M]
+
, 401 (2), 303 (6), 291 (29), 181 (10), 169 (100), 152 (33), 
137 (22), 123 (12), 121 (11), 109 (47), 105 (59), 84 (51), 77 (13), 43 (22); HRMS (ESI): m/z: 
calcd for C27H36O7Na [M + Na]
+
: 495.2353; found 495.2354. 
Compound 73: Me3SiCl (110 µL, 0.85 mmol) and triethylamine (120 µL, 0.85 mmol) were 
added to a solution of ketone 70 (40 mg, 0.085 
mmol) in THF (2 mL) at –78 °C before 
LiHMDS (1 M in THF, 0.34 mL, 0.34 mmol) 
was slowly introduced and the resulting 
mixture stirred at –78 °C for 1 h. The reaction 
was then quenched with pH 7 phosphate buffer 
and the product extracted with CH2Cl2 (3 x 2 mL). The combined organic phases were dried 
over MgSO4 and evaporated to give the corresponding silyl enol ether, which was 
immediately used in the next step without further purification. 
Molecular sieves (4 Å, ca. 200 mg) and aldehyde 41b (13 mg, 0.085 mmol)
2
 were added to a 
solution of the crude silyl enol ether in propionitrile (1 mL). The mixture was cooled to          
–78 °C before a solution of compound 42 [prepared upon stirring of a solution of PhBCl2 (22 
µL, 0.17 mmol) and N-tosyl-D-tryptophane (61 mg, 0.17 mmol) in CH2Cl2 (1 mL) for 1 h, 
followed by removal of the solvent]
3
 in propionitrile (0.3 mL) was added dropwise. After 
stirring for 20 h at –78 °C, the reaction was quenched with sat. aq. NaHCO3 (2 mL), the 
aqueous phase was extracted with CH2Cl2 (3 x 5 mL), and the combined organic layers were 
dried over MgSO4 and evaporated. The resulting material was dissolved in THF (5 mL) at 
0 °C and treated with 2.5 mL of a stock solution of buffered HF∙pyridine [prepared from THF 
(7.25 mL), pyridine (2.69 mL) and HF∙pyridine complex (0.54 mL, 70 % w/w)]. The mixture 
was stirred at 0 °C for 30 min and then at ambient temperature for 4 h to complete the 
desilylation. Dilution with CH2Cl2 (20 mL), washing of the organic layer with sat. aq. 
NaHCO3 (10 mL) and aq. CuSO4 solution (1 M, 3 x 10 mL), drying over MgSO4 and 
evaporation of the solvents left a residue, which was purified by flash chromatography 
(EtOAc/hexanes, 80/20) to give product 73 as a white solid (30 mg, 57 %). 
1
H NMR (400 
MHz, CDCl3):  = 8.18 (br s, 1 H, 1 dia., overlap), 8.17 (br s, 1 H, 1 dia., overlap), 8.04 (d, 
J = 8.2 Hz, 2 H, 1 dia.), 8.00 (d, J = 8.3 Hz, 2 H, 1 dia.), 7.60–7.53 (m, 2 H, 2 dia.), 7.48–7.41 
(m, 4 H, 2 dia.), 5.81–5.64 (m, 2 H, 2 dia.), 5.54–5.46 (m, 2 H, 2 dia., overlap), 5.49–5.42 (m, 
1 H, 1 dia., overlap), 5.37 (dd, J = 15.9, 7.3 Hz, 1 H, 1 dia.), 5.18–5.12 (m, 2 H, 2 dia., 
overlap), 5.18–5.12 (m, 1 H, 1 dia., overlap), 4.97 (d, J = 3.4 Hz, 1 H, 1 dia.), 4.11–4.01 (m, 2 
H, 2 dia.), 3.79 (dd, J = 9.3, 0.9 Hz, 1 H, 1 dia.), 3.66 (dd, J = 9.4, 3.6 Hz, 1 H, 1 dia.), 3.46–
3.34 (m, 2 H, 2 dia.), 3.32 (s, 3 H, 1 dia.), 3.31 (s, 3 H, 1 dia.), 3.29–3.23 (m, 2 H, 2 dia.), 
3.16 (s, 1 H, 1 dia.), 3.11 (s, 1 H, 1 dia.), 2.93 (dd, J = 17.2, 3.9 Hz, 1 H, 1 dia.), 2.87 (dd, J = 
13.2, 3.0 Hz, 1 H, 1 dia.), 2.82–2.67 (m, 6 H, 2 dia.), 2.67–2.55 (m, 2 H, 2 dia.), 2.55–2.39 
(m, 6 H, 2 dia.), 2.38–2.23 (m, 6 H, 2 dia.), 2.22–2.11 (m, 2 H, 2 dia.), 2.10–1.99 (m, 4 H, 2 
dia.), 1.90 (d, J = 0.9 Hz, 3 H, 1 dia.), 1.79 (d, J = 1.0 Hz, 3 H, 1 dia.), 1.63–1.51 (m, 2 H, 2 
dia.), 1.42–1.33 (m, 2 H, 2 dia.), 1.13 (d, J = 6.8 Hz, 6 H, 2 dia.), 0.93 (d, J = 7.3 Hz, 3 H, 1 
dia., overlap), 0.92 ppm (d, J = 7.2 Hz, 3 H, 1 dia., overlap); 
13
C NMR (100 MHz, CDCl3): 
 = 212.1 (C), 211.9 (C), 172.5 (C), 172.5 (C), 172.4 (C), 172.4 (C), 169.3 (C), 168.7 (C), 
166.2 (C), 165.6 (C), 136.7 (CH), 136.4 (CH), 134.8 (C), 134.5 (C), 133.3 (CH), 133.2 (CH), 
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131.7 (CH), 130.3 (C), 130.1 (C), 129.8 (CH), 129.7 (CH), 128.8 (CH), 128.6 (CH), 128.5 
(CH), 126.8 (CH, 2 dia.), 83.1 (CH), 82.4 (CH), 80.6 (CH), 80.0 (CH), 71.7 (CH), 71.4 (CH), 
71.4 (CH), 69.7 (CH), 65.1 (CH, 2 dia.), 56.7 (CH3), 56.5 (CH3), 47.5 (CH2), 47.2 (CH2), 46.7 
(CH), 46.7 (CH), 41.2 (CH2), 41.1 (CH2), 40.9 (CH2), 38.6 (CH2), 38.5 (CH2), 38.4 (CH), 
37.7 (CH), 37.5 (CH2), 37.4 (CH2), 37.3 (CH2), 37.3 (CH2), 33.5 (CH2), 27.3 (CH), 27.2 
(CH), 26.5 (CH2, 2 dia.), 15.8 (CH3), 15.5 (CH3), 14.0 (CH3), 13.7 (CH3), 11.3 (CH3), 11.0 
ppm (CH3); IR (film): 3469, 2968, 2930, 2875, 1697, 1450, 1374, 1314, 1260, 1190, 1150, 
1106, 1069, 1025, 980, 932, 752, 712 cm
-1
; HRMS (ESI): m/z: calcd for C34H45NO10Na [M + 
Na]
+
: 650.2936; found 650.2936. 
Compound 74. Imidazole (53 mg, 0.78 mmol) and resin-supported triphenylphosphine (3 
mmol/g on polystyrene, 53 mg, 0.16 mmol) 
were added to a solution of diol 73 (33 mg, 
0.052 mmol) in CH2Cl2 (3 mL) at 0 °C. Next, 
iodine (46 mg, 0.18 mmol) was introduced and 
the resulting mixture stirred at ambient 
temperature for 1.5 h. The reaction was diluted 
with CH2Cl2 (10 mL) and the resin filtered off. The filtrate was extracted with pH 7 phosphate 
buffer and the aqueous phase extracted with CH2Cl2 (10 mL). The combined organic phases 
were dried over MgSO4 and evaporated. The residue was purified by flash chromatography 
(EtOAc/hexanes, 5/5 → 2/8) to give product 74 as a white solid (19 mg, 60 %). 1H NMR (400 
MHz, CDCl3):  = 8.08–7.97 (m, 6 H, 2 dia.), 7.60–7.53 (m, 2 H, 2 dia.), 7.48–7.41 (m, 4 H, 
2 dia.), 6.79–6.68 (m, 2 H, 2 dia.), 6.31 (d, J = 15.4 Hz, 1 H, 1 dia.), 6.22 (d, J = 15.6 Hz, 1 
H, 1 dia.), 5.81–5.67 (m, 2 H, 2 dia.), 5.55–5.46 (m, 2 H, 2 dia., overlap), 5.50–5.43 (m, 1 H, 
1 dia., overlap), 5.38 (dd, J = 15.9, 7.2 Hz, 1 H, 1 dia.), 5.18 (d, J = 9.7 Hz, 2 H, 2 dia.), 5.15 
(d, J = 3.3 Hz, 1 H, 1 dia.), 4.98 (d, J = 3.7 Hz, 1 H, 1 dia.), 3.81 (dd, J = 9.3, 1.1 Hz, 1 H, 1 
dia.), 3.67 (dd, J = 9.4, 3.6 Hz, 1 H, 1 dia.), 3.58–3.47 (m, 2 H, 2 dia.), 3.33 (s, 3 H, 1 dia., 
overlap), 3.31 (s, 3 H, 1 dia., overlap), 3.31–3.22 (m, 2 H, 2 dia., overlap), 2.92 (dd, J = 17.2, 
3.9 Hz, 1 H, 1 dia.), 2.87 (dd, J = 13.0, 2.7 Hz, 1 H, 1 dia.), 2.75–2.64 (m, 6 H, 2 dia.), 2.54 
(dd, J = 13.3, 10.7 Hz, 1 H, 1 dia.), 2.49–2.38 (m, 2 H, 2 dia.), 2.38–2.22 (m, 12 H, 2 dia.), 
2.21–2.12 (m, 2 H, 2 dia.), 2.10–1.96 (m, 5 H, 2 dia.), 1.93 (d, J = 1.0 Hz, 3 H, 1 dia.), 1.82 
(d, J = 1.0 Hz, 3 H, 1 dia.), 1.15 (d, J = 6.8 Hz, 6 H, 2 dia.), 0.90 (d, J = 7.3 Hz, 3 H, 1 dia., 
overlap), 0.83 ppm (d, J = 7.1 Hz, 3 H, 1 dia., overlap); 
13
C NMR (100 MHz, CDCl3):  = 
199.8 (C), 199.6 (C), 171.7 (C, 2 dia.), 171.7 (C, 2 dia.), 169.3 (C), 169.2 (C), 165.6 (C, 2 
dia.), 141.6 (CH), 141.3 (CH), 136.7 (CH), 136.5 (CH), 134.3 (C), 133.9 (C), 133.3 (CH), 
133.2 (CH), 131.4 (CH), 131.1 (CH), 130.4 (C, 2 dia.), 129.8 (CH), 129.7 (CH), 129.0 (CH), 
128.8 (CH), 128.6 (CH), 128.5 (CH), 127.5 (CH, 2 dia.), 83.2 (CH), 82.6 (CH), 80.3 (CH, 2 
dia.), 71.7 (CH, 2 dia.), 71.4 (CH, 2 dia.), 56.7 (CH3), 56.5 (CH3), 44.9 (CH2, 2 dia.), 44.8 
(CH), 44.8 (CH), 37.7 (CH2, 2 dia.), 37.6 (CH2, 2 dia.), 37.5 (CH, 2 dia.), 37.3 (CH2, 2 dia.), 
30.5 (CH2, 2 dia.), 29.8 (CH), 29.8 (CH), 26.6 (CH2), 22.7 (CH2), 15.8 (CH3, 2 dia.), 13.9 
(CH3, 2 dia.), 11.3 ppm (CH3, 2 dia.); IR (film): 3493, 3226, 2968, 2926, 2875, 1695, 1627, 
1450, 1374, 1315, 1268, 1191, 1150, 1107, 1069, 1043, 1025, 979, 931, 804, 712 cm
-1
; 
HRMS (ESI): m/z: calcd for C34H43NO9Na [M + Na]
+
: 632.2830; found 632.2829. 
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Compound 76. A solution of the copper complex 75 (1 M in toluene, 1.8 mL, 1.8 mmol) was 
added to enone 74 (11 mg, 0.018 mmol). The 
solvent was slowly evaporated by a stream of 
argon until a precipitate formed. After stirring 
for 14 h at ambient temperature, the mixture was 
diluted with CH2Cl2 and the solvents were 
evaporated. The residue was purified by flash 
chromatography (EtOAc/hexanes, 15/85 → 70/30) to give product 76 as a white solid (6.5 
mg, 59 %). 
1
H NMR (400 MHz, CDCl3):  = 8.06-8.00 (m, 4 H, 2 dia.) 7.85 (br s, 1 H, 1 dia), 
7.81 (br s, 1 H, 1 dia), 7.60-7.59 (m, 2 H, 2 dia.) 7.48-7.42 (m, 4 H, 2 dia.), 5.79-5.69 (m, 2 
H, 2 dia.), 5.54-5.48 (m, 2 H, 2 dia., overlap), 5.47 (dd, J = 15.7, 6.8 Hz, 1 H, 1 dia,overlap), 
5.38 (dd, J = 16.0, 7.3 Hz, 1 H, 1 dia,overlap), 5.18 (d, J = 9.8 Hz, 2 H, 2 dia.), 5.14 (d, J = 
3.2 Hz, 1 H, 1 dia.), 4.98 (d, J = 3.8 Hz, 1 H, 1 dia.), 3.79 (d, J = 9.0 Hz, 1 H, 1 dia.), 3.66 
(dd, J = 9.4, 3.6 Hz, 1 H, 1 dia.), 3.46-3.36 (m, 2 H, 2 dia.), 3.33 (s, 3 H, 1 dia., overlap), 3.31 
(s, 3 H, 1 dia., overlap), 3.33-3.34 (m, 2 H, 2 dia., overlap), 3.06 (s, 1 H, 1 dia.), 2.96 (s, 1 H, 
1 dia.), 2.92 (dd, J = 17.3, 4.0 Hz, 1 H, 1 dia.), 2.87 (dd, J = 13.3, 3.0 Hz, 1 H, 1 dia), 2.74-
2.66 (m, 4 H, 2 dia., overlap), 2.68 (dd, J = 16.8, 4.2 Hz, 1 H, 1 dia, overlap), 2.63-2.57 (m, 1 
H, 1 dia., overlap), 2.61-2.43 (m, 4 H, 2 dia., overlap), 2.47-2.31 (m, 4 H, 2 dia., overlap), 
2.33-2.20 (m, 4 H, 2 dia., overlap), 2.18-2.09 (m, 2 H, 2 dia., overlap), 2.16-2.00 (m, 2 H, 2 
dia., overlap), 2.15-1.93 (m, 4 H, 2 dia., overlap), 1.90 (d, J = 1.2 Hz, 3 H, 1 dia.), 1.81 (d, 
J = 1.2 Hz, 3 H, 1 dia.), 1.61-1.54 (m, 4 H, 2 dia.), 1.38-1.32 (m, 4 H, 2 dia.), 1.12 (d, J = 6.6 
Hz, 3 H, 1 dia., overlap), 1.12 ppm (d, J = 6.8 Hz, 3 H, 1 dia., overlap), 0.91 (d, J = 7.2 Hz, 6 
H, 2 dia.);
 13
C NMR (100 MHz, CDCl3):  = 210.8 (C), 210.7 (C), 172.2 (C, 2 dia.), 172.2 (C, 
2 dia.), 169.3 (C), 168.7 (C), 166.2 (C), 165.6 (C), 136.6 (CH), 134.4 (CH), 134.1 (C), 133.7 
(C), 133.3, (CH), 133.2 (CH), 131.7 (CH), 130.4 (C), 130.2 (C), 129.8 (CH), 129.7 (CH), 
128.8 (CH), 128.6 (CH), 128.5 (CH), 128.1 (CH), 127.7 (CH), 83.2 (CH), 82.5 (CH), 80.8 
(CH), 80.2 (CH), 71.6 (CH), 71.4 (CH, 2 dia.), 69.7 (CH), 56.7 (CH3), 56.5 (CH3), 46.2 (CH, 
2 dia.), 41.0 (CH2), 40.1 (CH2), 38.4 (CH), 37.9 (CH), 37.9 (CH2, 2 dia.), 37.7 (CH2), 37.6 
(CH2), 34.3 (CH2, 2 dia.), 30.5 (CH2, 2 dia.), 30.4 (CH2), 30.3 (CH2), 27.3 (CH2), 26.6 (CH2), 
20.4 (CH2, 2 dia.), 16.1 (CH3), 15.9 (CH3), 13.9 (CH3), 13.5 (CH3), 11.3 (CH3), 11.0 ppm 
(CH3); IR (film): 3522, 3230, 2931, 1704, 1601, 1450, 1372, 1314, 1270, 1191, 1150, 1108, 
1069, 1044, 1026, 982, 932, 851, 804, 713 cm
-1
; HRMS (ESI): m/z: calcd for C34H45NO9Na 
[M + Na]
+
: 634.2987; found 634.2988. 
Compound 77: NaBH4 (2.5 mg, 0.065 mmol) was added to a solution of ketone 76 (8.0 mg, 
0.013 mmol) in THF (0.5 mL) at 0 °C. After stirring 
for 1 h at this temperature, a second portion of 
NaBH4 (2.5 mg, 0.065 mmol) was introduced and 
stirring continued at ambient temperature for 2 h. The 
reaction was quenched with sat. aq. NH4Cl and 
diluted with CH2Cl2. The aqueous layer was extracted 
with CH2Cl2 and the combined organic phases were dried over Na2SO4 and evaporated.  
DBU (30 μL, 0.20 mmol) was added to a solution of the crude alcohol in THF (0.6 mL). The 
resulting mixture was stirred at ambient temperature for 18 h before the solvents were 
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evaporated and the residue was purified by flash chromatography (hexanes/EtOAc, 80/20  
25/75) to give product 77 as a white solid (4.7 mg, 73 % over two steps). 
1
H NMR (400 MHz, 
CDCl3):  = 7.79 (br s, 2 H, 2 dia.), 6.69 (dt, J = 16.1, 8.1 Hz, 2 H, 2 dia.), 5.72 (d, J = 16.1 
Hz, 1 H, 1 dia.), 5.70 (d, J = 15.9 Hz, 1 H, 1 dia.), 5.66-5.58 (m, 2 H, 2 dia.), 5.24 (d, J = 3.2 
Hz, 1 H, 1 dia.), 5.21 (d, J = 3.6 Hz, 1 H, 1 dia.), 5.15-5.09 (m, 2 H, 2 dia., overlap), 5.11-
5.03 (m, 2 H, 2 dia., overlap), 3.75 (d, J = 9.0 Hz, 1 H, 1 dia.), 3.75 (d, J = 9.2 Hz, 1 H, 1 
dia.), 3.47-3.43 (m, 3 H, 2 dia.), 3.32 (s, 3 H, 1 dia.), 3.29 (s, 3 H, 1 dia.), 3.22-3.19 (m, 3 H, 
2 dia.), 3.12 (s, 1 H, 1 dia.), 2.99 (s, 1 H, 1 dia.), 2.79-2.68 (m, 5 H, 2 dia., overlap), 2.72 (dd, 
J = 16.7, 3.8 Hz, 2 H, 2 dia.), 2.67-2.60 (m, 2 H, 2 dia.), 2.48-2.40 (m, 2 H, 2 dia., overlap), 
2.46-2.39 (m, 1 H, 1 dia., overlap), 2.31-2.18 (m, 4 H, 2 dia., overlap), 2.20-2.12 (m, 1 H, 1 
dia., overlap), 2.18-2.10 (m, 2 H, 2 dia., overlap), 1.97 (dtd, J = 11.9, 11.9, 4.6 Hz, 2 H, 2 
dia.), 1.87-1.80 (m, 1 H, 1 dia., overlap), 1.86 (s, 6 H, 2 dia., overlap), 1.65-1.52 (m, 4 H, 2 
dia.), 1.47-1.34 (m, 6 H, 2 dia.), 1.34-1.21 (m, 2 H, 2 dia.), 0.99 (d, J = 6.8 Hz, 3 H, 1 dia.), 
0.94 (d, J = 6.6 Hz, 3 H, 1 dia.), 0.94 (d, J = 7.2 Hz, 3 H, 1 dia.), 0.91 ppm (d, J = 7.4 Hz, 3 
H, 1 dia.); 
13
C NMR (100 MHz, CDCl3):  = 172.3 (C, 2 dia.), 172.3 (C, 2 dia.), 168.3 (C), 
168.1 (C), 151.0 (CH), 150.9 (CH), 133.7 (C), 133.6 (C), 130.8 (CH), 130.3 (CH), 130.1 
(CH), 129.6 (CH), 129.5 (CH), 129.4 (CH), 125.2 (CH), 125.1 (CH), 82.6 (CH), 82.2 (CH), 
81.6 (CH), 81.3 (CH), 76.1 (CH), 75.9 (CH), 74.3 (CH), 74.1 (CH), 57.2 (CH3, 2 dia.), 39.2 
(CH), 38.5 (CH), 38.3 (CH), 38.1 (CH), 38.0 (CH2, 2 dia.), 38.0 (CH2, 2 dia.), 35.2 (CH2), 
34.9 (CH2), 33.8 (CH2), 33.1 (CH2), 33.1 (CH2), 32.5 (CH2), 30.6 (CH), 30.3 (CH2), 30.0 
(CH), 30.0 (CH2), 23.2 (CH2), 22.8 (CH2), 16.8 (CH3), 16.7 (CH3), 13.9 (CH3), 13.7 (CH3), 
10.8 (CH3), 10.8 ppm (CH3); IR (film): 3458, 3221, 2930, 2857, 1695, 1645, 1438, 1378, 
1325, 1249, 1188, 1146, 1102, 1034, 995, 974, 922, 874, 849, 831, 749, 721, 695, 665 cm
-1
; 
HRMS (ESI): m/z: calcd for C27H41NO7Na [M + Na]
+
: 514.2775; found 514.2781. 
Isomigrastatin (2). Dess-Martin periodinane (10 g, 0.024 mmol) was added to a solution of 
alcohol 77 (4.0 mg, 0.008 mmol) in CH2Cl2 (0.5 mL) 
at 0 °C. After stirring for 1 h at this temperature, a 
few drops of EtOH were added and the solvents 
evaporated. The residue was purified by flash 
chromatography (hexanes/EtOAc, 5/5  4/6), to 
afford product 2 as a white solid (2.5 mg, 64 %).  20D = +182° (c = 0.21, CHCl3); 
1
H NMR 
(600 MHz, CDCl3):  = 7.74 (br s, 1H), 6.65 (ddd, J = 16.0, 9.0, 7.1 Hz, 1H), 5.68 (d, J = 
16.0 Hz, 1H), 5.59 (ddd, J = 15.8, 11.0, 4.7 Hz, 1H), 5.21-5.18 (m, 2H), 5.09 (dd, J = 15.8, 
3.7 Hz, 1H), 3.74 (d, J = 9.2 Hz, 1H), 3.48-3.41 (m, 2H), 3.33 (s, 3H), 2.84 (br s, 1H), 2.70 
(dd, J = 17.3, 4.1 Hz, 2H), 2.65-2.59 (m, 2H), 2.45 (dddd, J = 11.6, 7.6, 3.9, 3.9 Hz, 1H), 
2.38 (dt, J = 17.9, 6.9 Hz, 1H), 2.24 (ddd, J = 17.3 , 10.6, 2.9 Hz, 2H), 2.19-2.09 (m, 2H), 
1.95 (qd, J = 12.2, 4.5 Hz, 1H), 1.90 (d, J = 1.1 Hz, 3H), 1.87-1.82 (m, 1H), 1.61-1.56 (m, 
2H), 1.39-1.33 (m, 2H), 1.13 (d, J = 6.8 Hz, 3H), 0.84 ppm (d, J = 7.1 Hz, 3H);
 13
C NMR 
(150 MHz, CDCl3):  = 210.9 (C), 172.2 (C), 167.8 (C), 150.8 (CH), 134.2 (C), 130.4 (CH), 
129.2 (CH), 128.1 (CH), 125.1 (CH), 82.3 (CH), 81.7 (CH), 73.3 (CH), 57.2 (CH3), 46.1 
(CH), 40.1 (CH2), 38.2 (CH), 37.9 (CH2), 37.9 (CH2), 34.3 (CH2), 32.9 (CH2), 30.3 (CH), 
30.2 (CH2), 20.4 (CH2), 15.9 (CH3), 13.4 (CH3), 10.7 ppm (CH3); IR (film): 3500, 3223, 
2961, 2929, 1698, 1443, 1405, 1359, 1325, 1259, 1187, 1147, 1100, 1034, 995, 974, 941, 922, 
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872, 800, 734, 694, 675 cm
-1
; HRMS (ESI): m/z: calcd for C27H39NO7Na [M + Na]
+
: 
512.2619; found: 512.2622. 
Table S-3. Comparison of the recorded 
1
H NMR data (CDCl3) of isomigrastatin (2) with 
those reported in literature;
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5.68 d (16.0) 




1.96 qd (12.0, 4.7) 
5.60 ddd (15.7, 10.9, 4.7) 
5.10 dd (15.7, 3.9) 
3.46 m 










2.70 dd (17.0, 4.0) 
? dd (17.0, 10.8) 
3.33 s 
0.84 d (7.2) 
1.91 d (1.2) 
1.14 d (6.7) 
2.70 dd (17.3, 4.1) 
2.24 ddd (17.3 , 10.6, 2.9) 
5.68 d (16.0) 
6.65 ddd (16.0, 9.0, 7.1) 
2.45 dddd (11.6, 7.6, 3.9, 3.9) 
2.14 m 
2.62 m 
1.95 qd (12.2, 4.5) 
5.59 ddd (15.8, 11.0, 4.7) 
5.09 dd (15.8, 3.7) 
3.45 m 










2.70 dd (17.3, 4.1) 
2.24 ddd (17.3 , 10.6, 2.9) 
3.33 s 
0.84 d (7.1) 
1.90 d (1.1) 
1.13 d (6.8) 
2.70 dd (17.3, 4.1) 




























                                                 
7
  I. J. Krauss, M. Mandal, S. J. Danishefsky, Angew. Chem. 2007, 119, 5672-5675; Angew. Chem. Int. 





7.71 br s 
2.84 br s 
7.74 br s 
2.84 br s 
+0.3 
0 
Table S-4. Comparison of the recorded 
13
C NMR data (δ in ppm, CDCl3) of isomigrastatin 




















































































































Compound 44. Catecholborane (26 μL, 0.24 mmol) was added to a solution of compound 1 
(11.2 mg, 0.024 mmol) in THF (0.8 mL) at –78 °C. 
The mixture was warmed to –5 °C and stirred for 2 h 
at this temperature before the mixture was diluted 
with pH 7 phophate buffer and CH2Cl2. The aqueous 
layer was extracted with CH2Cl2, and the combined 
organic layers were dried over Na2SO4 and evaporated. The residue was purified by flash 
chromatography (hexanes/EtOAc, 5/5  0/1) to give syn-diol 44 as a white solid (6.4 mg, 
58 %).  20D = –1.9° (c = 0.31, CHCl3); 
1
H NMR (600 MHz, CDCl3):  = 7.76 (s, 1H), 6.45 
(ddd, J = 16.1, 10.2, 5.1 Hz, 1H), 6.03 (t, J = 10.8 Hz, 1H), 5.70 (dd, J = 10.7, 15.6 Hz, 1H), 
5.53 (d, J = 16.7 Hz. 1H), 5.40 (ddd, J = 15.6, 9.0, 6.2 Hz, 1H), 5.32 (d, J = 4.8 Hz, 1H), 5.28 
(d, J = 9.9 Hz, 1H), 5.06 (t, J = 10.9 Hz, 1H), 3.96-3.91 (m, 1H), 3.91 (br s, 1H), 3.67-3.63 
(m, 1H), 3.13-3.07 (m, 1H), 2.79 (dd, J = 17.1, 4.1 Hz, 1H), 2.74 (dd, J = 17.1, 4.2 Hz, 1H), 
2.58-2.54 (m, 1H), 2.54-2.45 (m, 3H), 2.32 (dd, J = 17.1, 10.1 Hz, 1H), 2.31 (dd, J = 17.1, 
10.3 Hz, 1H), 2.15 (br s, 1H), 1.99-1.88 (m, 2H), 1.71 (d, J = 1.3 Hz, 3H), 1.64-1.59 (m, 2H), 
1.47 (ddd, J = 14.3, 10.7, 9.7 Hz, 1H), 1.37 (ddd, J = 13.8, 9.1, 3.0 Hz, 1H), 0.96 (d, J = 6.8 
Hz, 3H), 0.91 ppm (d, J = 6.8 Hz, 3H);
 13
C NMR (150 MHz, CDCl3):  = 172.3 (C), 172.3 
(C), 166.8 (C), 146.8 (CH), 134.6 (CH), 133.6 (C), 131.8 (CH), 131.4 (CH), 129.4 (CH), 
128.4 (CH), 128.1 (CH), 82.9 (CH), 69.3 (CH), 69.1 (CH), 42.4 (CH2), 40.7 (CH2), 39.8 
(CH), 38.7 (CH2), 37.3 (CH2), 35.7 (CH), 32.4 (CH2), 31.3 (CH2), 27.0 (CH), 17.8 (CH3), 
16.6 (CH3), 15.5 ppm (CH3); IR (film): 3268, 2970, 1720, 1693, 1454, 1365, 1261, 1178, 
1151, 1068, 1035, 962, 926, 847, 770, 724 cm
-1
; HRMS (ESI): m/z: calcd for C26H37NO6Na 
[M + Na]
+
: 482.2513; found: 482.2514. 
Compound 45. A solution of MsCl (63 μL, 0.2 M in CH2Cl2) and triethylamine (7.6 μL, 
0.055 mmol) was added to a solution of compound 1 
(5.0 mg, 0.011 mmol) in CH2Cl2 (0.2 mL) at 0 °C. 
After stirring for 2 h at this temperature, pH 7 
phophate buffer and CH2Cl2 were added, the aqueous 
layer was extracted with CH2Cl2, and the combined 
organic layers were dried over Na2SO4 and 
evaporated. The residue was purified by flash chromatography (hexanes/EtOAc, 50/50  
30/70) to give enone 45 as a white solid (3.5 mg, 72 %).  20D = +41.5° (c = 0.35, CHCl3); 
1
H 
NMR (600 MHz, CDCl3):  = 7.88 (s, 1H), 6.78 (dt, J = 15.0, 7.5 Hz, 1H), 6.47 (ddd, J = 
16.0, 10.5, 5.4 Hz, 1H), 6.24 (d, J = 15.4 Hz, 1H), 6.04 (t, J = 10.8 Hz, 1H), 5.71 (dd, J = 
10.0, 15.5 Hz, 1H), 5.54 (s, J = 16.1 Hz, 1H), 5.41 (ddd, J = 15.5, 9.2, 6.2 Hz, 1H), 5.37 (d, 
J = 9.5 Hz, 1H), 5.34 (d, J = 4.6 Hz, 1H), 5.05 (t, J = 10.9 Hz, 1H), 3.57-3.51 (m, 1H), 3.12-
3.05 (m, 1H), 2.71 (d, J = 13.9 Hz, 2H), 2.59-2.54 (m, 1H), 2.54-2.49 (m, 1H), 2.38-2.27 (m, 
5H), 1.99-1.87 (m, 2H), 1.77 (d, J = 1.3 Hz, 3H), 1.20 (d, J = 6.8 Hz, 3H), 0.88 ppm (d, J = 
7.0 Hz, 3H);
 13
C NMR (150 MHz, CDCl3):  = 199.3 (C), 171.3 (C), 171.2 (C), 166.7 (C), 
146.8 (CH), 141.9 (CH), 134.6 (CH), 133.6 (C), 131.5 (CH), 130.8 (CH), 129.4 (CH), 129.3 
(CH), 128.3 (CH), 128.1 (CH), 82.7 (CH), 45.1 (CH), 37.5 (CH2), 37.5 (CH2), 37.4 (CH2), 
36.0 (CH), 32.4 (CH2), 31.3 (CH2), 29.8 (CH), 17.5 (CH3), 16.3 (CH3), 15.3 ppm (CH3); IR 
(film): 3241, 2962, 2931, 1694, 1626, 1451, 1374, 1259, 1189, 1144, 1087, 988, 915, 798, 
727 cm
-1
; HRMS (ESI): m/z: calcd for C26H33NO5Na [M + Na]
+
: 462.2251; found: 462.2254. 
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Compound 46. Acid 41a (11 mg, 0.064 mmol), DMAP (8 mg, 0.064 mmol) and EDCI (12 
mg, 0.064 mmol) were successively added to solution 
of alcohol 39 (15 mg, 0.049 mmol) in THF (0.5 mL) at 
0 °C. After stirring for 2 h at ambient temperature, the 
reaction was quenched with pH 7 phophate buffer and 
CH2Cl2. The aqueous layer was extracted with CH2Cl2, 
and the combined organic phases were dried over 
Na2SO4 and evaporated. The residue was purified by 
flash chromatography (hexanes/EtOAc, 85/15  70/30) to give ester 46 as a white solid (9 
mg, 55 % brsm).  20D = –47° (c = 1.0, THF); 
1
H NMR (400 MHz, CDCl3):  = 7.89 (s, 1H), 
6.47 (ddd, J = 16.0, 10.4, 5.4 Hz, 1H), 6.04 (t, J = 10.8 Hz, 1H), 5.73 (dd, J = 15.6, 10.7 Hz, 
1H), 5.54 (d, J = 16.1 Hz, 1H), 5.41 (ddd, J = 15.5, 9.1, 6.2 Hz, 1H), 5.32 (d, J = 4.9 Hz, 
1H), 5.29 (d, J = 9.6 Hz, 1H), 5.09 (t, J = 10.9 Hz, 1H), 4.92-4.86 (m, 1H), 3.11-3.05 (m, 
1H), 2.78 (dd, J = 17.3, 4.2 Hz, 2H), 2.69-2.59 (m, 2H), 2.58-2.49 (m, 2H), 2.42-2.33 (m, 
4H), 2.01-1.87 (m, 2H), 1.71.(d, J = 1.5 Hz, 3H), 1.19 (d, J = 6.4 Hz, 3H), 0.98 (d, J = 6.8 
Hz, 3H), 0.91 ppm (d, J = 6.9 Hz, 3H); 
13
C NMR (101 MHz, CDCl3):  = 170.7 (C), 170.7 
(C), 169.8 (C), 166.4 (C), 146.2 (CH), 134.1 (CH), 131.6 (CH), 131.4 (C), 131.3 (CH), 128.7 
(CH), 127.9 (CH), 127.5 (CH), 82.8 (CH), 74.3 (CH), 38.6 (CH2), 36.9 (CH2), 36.9 (CH2), 
36.5 (CH), 35.3 (CH), 31.9 (CH2), 30.9 (CH2), 26.8 (CH), 17.1 (CH3), 17.0 (CH3), 15.8 
(CH3), 14.3 ppm (CH3); IR (film): 3224, 2964, 2932, 2875, 1699, 1642, 1452, 1377, 1327, 
1289, 1259, 1189, 1142, 1087, 1067, 998, 957, 912, 848, 828, 795, 766, 728 cm
-1
; HRMS 
(ESI): m/z: calcd for C26H35NO6Na [M + Na]
+
: 480.2357; found: 480.2362. 
Compound 47. Dess-Martin periodinane (61 mg, 0.14 mmol) was added to solution of 
alcohol 23 (36 mg, 0.12 mmol) in CH2Cl2 (5 mL) at 0 °C. After 
stirring for 1 h at ambient temperature, the solvent was evaporated and 
the residue purified by flash chromatography (hexanes/EtOAc, 95/5) 
to give ketone 47 as a yellowish solid (32 mg, 89 %). M.p. 75-76 °C; 
 20D = +113° (c = 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 
6.18-6.05 (m, 2H), 5.69 (dt, J = 15.2, 5.3 Hz, 1H), 5.20 (d, J = 10.4 
Hz, 1H), 5.08 (d, J = 5.0 Hz, 1H), 4.98 (t, J = 9.8 Hz, 1H), 3.36-3.29 (m, 2H), 2.32-2.20 (m, 
3H), 2.06 (s, 3H), 1.99-1.89 (m, 2H), 1.85-1.76 (m, 1H), 1.64 (d, J = 1.3 Hz, 3H), 1.54-1.42 
(m, 2H), 1.07 (d, J = 6.8 Hz, 3H), 0.88 ppm (d, J = 6.9 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3):  = 208.7 (C), 172.6 (C), 133.8 (C), 131.2 (CH), 130.5 (CH), 130.0 (CH), 129.5 
(CH), 126.1 (CH), 82.1 (CH), 46.5 (CH), 33.4 (CH), 32.8 (CH2), 29.9 (CH2), 27.6 (CH3), 23.5 
(CH2), 22.6 (CH2), 17.2 (CH3), 15.8 (CH3), 14.3 ppm (CH3); ); IR (film): 2970, 2932, 2878, 
1726,1706, 1451, 1417, 1375, 1353, 1334, 1254, 1196, 1158, 1142, 1074, 1053, 1002, 967, 
909, 967, 881, 831, 795, 760 cm
-1
; MS (EI): m/z (%): 304 (4) [M+], 165 (12), 164 (100), 149 
(7), 136 (19), 135 (18), 123 (7), 121 (22), 120 (61), 108 (5), 107 (22), 120 (61), 108 (5), 107 
(22), 105 (10), 95 (9), 94 (23), 93 (18), 92 (5), 91 (13), 82 (5), 81 (14), 80 (7), 79 (31), 77 
(11), 69 (6), 68 (27), 67 (15), 55 (12), 53 (7), 43 (28), 41 (19), 29 (6); HRMS (ESI): m/z: 
calcd for C19H28O3 [M]
+
: 304.2038; found: 304.2040. 
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Compound 48. Me3SiCl (58 μL, 0.45 mmol) and triethylamine (63 μL, 0.45 mmol) were 
added to a solution of ketone 47 (13.6 mg, 0.045 
mmol) in THF (1.6 mL) at –78 °C. Next, LiHMDS 
(1 M in THF, 90 μL, 0.090 mmol) was slowly 
introduced and the resulting mixture stirred at –
78 °C for 1 h. The reaction was then quenched with 
pH 7 phosphate buffer and the product extracted 
with CH2Cl2 (3 x 2 mL). The combined organic phases were dried over MgSO4 and 
evaporated to give the corresponding silyl enol ether, which was used in the next step without 
further purification. 
Molecular sieves (4 Å, ca. 150 mg) and aldehyde 41b (7.0 mg, 0.045 mmol) were added to a 
solution of the crude silyl enol ether in propionitrile (0.8 mL). The mixture was cooled to       
–78 °C before a solution of compound 42 [prepared upon stirring of a solution of PhBCl2 (6 
µL, 0.045 mmol) and N-tosyl-D-tryptophane (16.1 mg, 0.045 mmol) in CH2Cl2 (0.4 mL) for 1 
h, followed by removal of the solvent]
3
 in propionitrile (0.3 mL) was slowly added. After 
stirring for 35 h at –78 °C, the reaction was quenched with sat. aq. NaHCO3, the aqueous 
phase extracted with CH2Cl2 (3 x 2 mL), and the combined organic layers were dried over 
Na2SO4 and evaporated. The resulting material was dissolved in THF (8 mL) at 0 °C and 
treated with 0.85 mL of buffered HF∙pyridine solution [prepared from THF (7.25 mL), 
pyridine (2.69 mL) and HF∙pyridine complex (0.59 mL, 70 % w/w)]. The mixture was stirred 
at 0 °C for 2 h and warmed to ambient temperature for 30 min to complete the desilylation. 
Dilution with CH2Cl2 (25 mL), washing of the organic layer with sat. aq. NaHCO3 (15 mL) 
and CuSO4 solution (1 M, 3 x 15 mL), drying over Na2SO4 and evaporation of the solvents 
left a residue, which was purified by preparative TLC (EtOAc/hexanes, 4/1) to give product 
48 as a white solid (6.3 mg, 31 %).  20D = +73° (c = 0.21, CHCl3); 
1
H NMR (600 MHz, 
CDCl3):  = 7.81 (s, 1H), 6.11-6.02 (m, 2H), 5.66 (dt, J = 15.2, 5.3 Hz, 1H), 5.13  (d, J = 9.6 
Hz, 1H), 5.03 (d, J = 5.1 Hz, 1H), 4.91 (t, J = 9.8 Hz, 1H), 4.02-3.96 (m, 1H), 3.31-3.24 (m, 
2H), 3.13 (br s, 1H), 2.69-2.63 (m, 2H), 2.45 (d, J = 5.7 Hz, 2H), 2.42-2.36 (m, 1H), 2.26-
2.15 (m, 5H), 1.93-1.86 (m, 2H), 1.79-1.73 (m, 1H), 1.59 (d, J = 1.3 Hz, 3H), 1.52-1.40 (m, 
3H), 1.23-1.17 (m, 1H), 1.04 (d, J = 6.8 Hz, 3H), 0.83 ppm (d, J = 6.9 Hz, 3H); 
13
C NMR 
(150 MHz, CDCl3):  = 212.3 (C), 173.0 (C), 172.0 (C), 171.8 (C), 134.8 (C), 131.7 (CH), 
130.5 (CH), 130.5 (CH), 128.9 (CH), 126.3 (CH), 82.1 (CH), 64.6 (CH), 47.3 (CH2), 46.5 
(CH), 40.6 (CH2), 38.4 (CH2), 37.0 (CH2), 33.6 (CH), 33.0 (CH2), 30.2 (CH2), 27.0 (CH), 
23.9 (CH2), 22.8 (CH2), 17.6 (CH3), 16.0 (CH3), 14.9 ppm (CH3); IR (film): 3451, 3223, 
2927, 1698, 1454, 1375, 1258, 1200, 1145, 1074, 1013, 994, 970, 872, 829, 789 cm
-1
; MS 
(EI): m/z (%): 459 (0.16) [M+], 165 (13), 164 (100), 149 (7), 146 (5), 136 (22), 135 (17), 121 
(19), 120 (49), 107 (19), 105 (9), 96 (8), 95 (6), 94 (19), 93 (16), 91 (11), 82 (5), 81 (14), 80 
(6), 79 (26), 77 (7), 69 (7), 68 (20), 67 (13), 55 (14), 53 (5), 43 (12), 41 (19), 29 (5); HRMS 
(ESI): m/z: calcd for C26H37NO6Na [M + Na]
+
: 482.2513; found: 482.2511. 
Compound S5. The Pt-catalyst 49 (15 mg, 0.022 mmol) and BnMe2SiH (0.35 mL, 2.23 
mmol) were dissolved in THF (1.5 mL) and heated to 60 °C for 3 h prior to addition of 
cycloalkyne 37 (240 mg, 0.445 mmol) as a solution in THF (2 mL). The mixture was stirred 
for 14 h at 60 °C. The solvent was evaporated and the residue purified by flash 
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chromatography (hexanes/EtOAc, 98/2  96/4) to give the alkenylsilane 50, which was 
directly used in the next step.  
A solution of TBAF (1 M in THF, 1.78 mL, 1.78 mmol) was added at 
0 °C to a solution of alkenylsilane 50 in THF (0.5 mL) and the 
resulting mixture was stirred at ambient temperature for 1 h. For work 
up, the solvent was evaporated and the residue purified by flash 
chromatography (hexanes/EtOAc, 85/15  75/25) to give (Z,Z)-
alkene S5 as a colorless oil, which contained  small impurites of 
(Z,E)-alkene (111 mg, 82 %).  20D = –60° (c = 0.82, CHCl3);
 1
H NMR (400 MHz, CDCl3): 
 = 6.86 (ddd, J = 15.7, 12.2, 3.5 Hz, 1H), 6.16 (t, J = 9.4 Hz, 1H), 6.10 (t, J = 9.4 Hz, 1H), 
5.56 (d, J = 15.5 Hz, 1H), 5.42-5.29 (m, 4H), 3.60 (qd, J = 6.3, 6.2 Hz, 1H), 2.92-2.83 (m, 
1H), 2.60-2.26 (m, 1H), 2.50-2.40 (m, 2H), 2.25-2.21 (m, 1H), 2.10 (qd, J = 12.3, 3.9 Hz, 
1H), 1.79 (d, J = 1.3 Hz, 3H), 1.61 (br s, 1H), 1.19 (d, J = 6.3 Hz, 3H), 1.00 (d, J = 6.8 Hz, 
3H), 0.91 ppm (d, J = 6.9 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 166.6 (C), 151.6 (CH), 
134.0 (CH), 132.7 (CH), 132.3 (C), 131.2 (CH), 127.8 (CH), 126.9 (CH), 123.9 (CH), 82.6 
(CH), 71.7 (CH), 40.4 (CH), 37.0 (CH), 32.6 (CH2), 26.8 (CH2), 20.4 (CH3), 16.8 (CH3), 16.7 
(CH3), 15.5 ppm (CH3); IR (film): 3466, 2967, 2928, 2872, 1708, 1451, 1376, 1319, 1247, 
1199, 1154, 1081, 997, 919, 851, 829, 731cm
-1
; MS (EI): m/z (%): 162 (30), 133 (10), 95 (8), 
94 (100), 93 (6), 91 (5), 79 (51), 77 (6), 68 (13), 41 (5); HRMS (ESI): m/z: calcd for 
C19H28O3Na [M + Na]
+
: 327.1931; found: 327.1929. 
Compound 51. Dess-Martin periodinane (75 mg, 0.18 mmol) was added to a solution of 
alcohol S5 (30 mg, 0.410mmol) in CH2Cl2 (3.5 mL) at 0 °C. After 
stirring for 4 h at ambient temperature the solvent was evaporated and 
the residue was purified by flash chromatography (hexanes/EtOAc, 
90/10) to give ketone 51 as a colorless oil that contained small 
impurites of the (Z,E)-isomer (23 mg, 77 %).  20D = +143° (c = 0.89, 
CHCl3);
 1
H NMR (400 MHz, CDCl3):  = 6.86 (ddd, J = 15.6, 12.1, 
3.5 Hz, 1H), 6.15 (t, J = 7.8 Hz, 1H), 6.11 (t, J = 7.6 Hz,1H), 5.54 (dd, J = 15.6, 1.4 Hz, 1H), 
5.41-5.29 (m, 4H), 3.44 (dq, J = 9.6, 6.8 Hz, 1H), 2.88 (dqd, J = 12.2, 6.4, 5.2 Hz, 1H), 2.60-
2.56 (m, 1H), 2.44 (qd, J = 12.1, 4.4 Hz, 1H), 2.26-2.19 (m, 1H), 2.13 (s, 3H), 2.11-2.08 (m, 
1H), 1.84 (d, J = 1.2 Hz, 3H), 1.18 (d, J = 6.8 Hz, 3H), 0.89 ppm (d, J = 6.9 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3):  = 208.8 (C), 165.9 (C), 151.5 (CH), 133.2 (CH), 133.1 (CH), 
130.9 (CH), 129.1 (C), 127.3 (CH), 126.6 (CH), 123.3 (CH), 81.6 (CH), 46.6 (CH), 36.9 
(CH), 32.1 (CH2), 27.6 (CH3), 26.3 (CH2), 16.2 (CH3), 15.9 (CH3), 15.0 ppm (CH3); IR 
(film): 2968, 2930, 1707, 1452, 1353, 1318, 1245, 1181, 1150, 999, 828, 731 cm
-1
; MS (EI): 
m/z (%): 162 (33), 133 (11), 95 (8), 94 (100), 93 (5), 79 (52), 77 (6), 68 (12), 43 (7); HRMS 
(ESI): m/z: calcd for C19H26O3Na [M + Na]
+
: 325.1774; found: 325.1775. 
Compound 52: Me3SiCl (88 μL, 0.69 mmol) and triethylamine (96 μL, 0.69 mmol) were 
added to a solution of ketone 51 (21 mg, 0.069 mmol) 
in THF (2 mL) at –78 °C. Next, LiHMDS (1 M in 
THF, 140 μL, 0.14 mmol) was slowly introduced and 
the resulting mixture stirred at –78 °C for 1 h. The 
reaction was then quenched with pH 7 phosphate 
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buffer and the product extracted with CH2Cl2 (3 x 5 mL). The combined organic phases were 
dried over MgSO4 and evaporated to give the corresponding silyl enol ether, which was used 
in the next step without purification. 
Molecular sieves (4 Å, ca. 200 mg) and aldehyde 41b (11 mg, 0.069 mmol) were added to a 
solution of the crude silyl enol ether in propionitrile (1.4 mL). The mixture was cooled to       
–78 °C before a solution of compound 42 [prepared upon stirring of a solution of PhBCl2 (13 
µL, 0.080 mmol) and N-tosyl-D-tryptophane (30 mg, 0.080 mmol) in CH2Cl2 (2.5 mL) for 1 
h, followed by removal of the solvent]
3
 in propionitrile (0.6 mL) was added dropwise. After 
stirring for 20 h at –78 °C, the reaction was quenched with sat. aq. NaHCO3, the aqueous 
phase extracted with CH2Cl2 (3 x 5 mL), and the combined organic layers were dried over 
Na2SO4 and evaporated. The resulting crude product was dissolved in THF (10 mL) at 0 °C 
and treated with 1.3 mL of buffered HF∙pyridine solution [prepared from THF (3.6 mL), 
pyridine (1.35 mL) and HF∙pyridine complex (0.27 mL, 70 % w/w)]. The mixture was stirred 
at 0 °C for 2 h and warmed to ambient temperature for 30 min. Dilution with CH2Cl2, washing 
of the organic layer with sat. aq. NaHCO3 and aq. CuSO4 solution (1 M), drying over Na2SO4 
and evaporation of the solvents left a residue, which was purified by preparative TLC 
(EtOAc/hexanes, 8/2) to give product 52 as a white solid (22 mg, 69 %) which contained 
small impurites of the (Z,E)-isomer.  20D = +75° (c = 0.5, CHCl3);
 1
H NMR (600 MHz, 
CDCl3):  = 7.97 (s, 1H), 6.84 (ddd, J = 15.6, 12.2, 3.5 Hz, 1H), 6.14-6.09 (m, 2H), 5.53 (dd, 
J = 15.6, 1.2 Hz, 1H), 5.37-5.30 (m, 4H), 4.11-4.06 (m, 1H), 3.42 (dq, J = 9.7, 6.8 Hz, 1H), 
3.25 (br s, 1H), 2.90-2.83 (m, 1H), 2.80-2.70 (m, 2H), 2.60-2.57 (m, 1H), 2.57-2.54 (m, 2H), 
2.50-2.38 (m, 2H), 2.31 (t, J = 10.4 Hz, 1H), 2.28 (t, J = 10.4 Hz, 1H), 2.25-2.18 (m, 1H), 
2.09 (qd, J = 12.4, 3.9 Hz, 1H), 1.81 (d, J = 1.3 Hz, 3H), 1.58 (ddd, J = 14.1, 10.6, 4.9 Hz, 
1H), 1.33-1.26 (m, 1H), 1.18 (d, J = 6.8 Hz, 3H), 0.87 ppm (d, J = 6.9 Hz, 3H); 
13
C NMR 
(150 MHz, CDCl3):  = 212.4 (C), 172.1 (C), 172.0 (C), 166.3 (C), 152.1 (CH), 134.3 (C), 
133.4 (CH), 131.5 (CH), 128.6 (CH), 127.7 (CH), 127.3 (CH), 123.7 (CH), 81.7 (CH), 65.0 
(CH), 47.4 (CH2), 46.8 (CH), 40.9 (CH2), 38.6 (CH2), 37.3 (CH), 37.2 (CH2), 32.6 (CH2), 
27.3 (CH), 26.8 (CH2), 16.8 (CH3), 16.3 (CH3), 15.8 ppm (CH3); IR (film): 3250, 2962, 2932, 
2874, 1697, 1453, 1374, 1249, 1149, 1065, 1034, 999, 917, 851, 829, 729 cm
-1
; HRMS (ESI): 
m/z: calcd for C26H35O6NNa [M + Na]
+
: 480.2357; found: 480.2354. 
Compound S6: A solution of TBAF.3H2O (1 M in THF, 0.51 mL, 0.51 mmol) was added at 
0 °C to a solution of alkenylsilane 53 (240 mg, 0.42 mmol) in THF 
(2.5 mL). The resulting orange mixture was stirred at 0 °C for 5 min 
before H2O (68 µL, 3.8 mmol) and TBAF∙3H2O (1 M in THF, 1.2 
mL, 1.2 mmol) were added. After stirring for 5 min at this 
temperature, iodobenzene (141 µL, 1.26 mmol) and 
(Pd2dba3)∙CHCl3 (43 mg, 0.042 mmol) were successively 
introduced. The mixture was stirred for 30 min at 0 °C and for 6 h at 
ambient temperature, before it was filtered through a pad of silica 
which was carefully rinsed with ethyl acetate. The combined filtrates were evaporated and the 
residue purified by flash chromatography (hexanes/EtOAc, 95/5  90/10) to give product S6 
as a pale brown oil (87 mg, 54 %).  20D = +48.5 (c = 0.42, CHCl3); 
1
H NMR (400 MHz, 
CDCl3):  = 7.36–7.27 (m, 2H), 7.27–7.21 (m, 1H), 7.20–7.14 (m, 2H), 6.08–6.00 (m, 2H), 
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5.32 (d, J = 9.8 Hz, 1H), 5.26 (d, J = 2.3 Hz, 1H), 5.19 (dd, J = 10.9, 10.9 Hz, 1H), 3.63 (qd, 
J = 6.2, 6.2 Hz, 1H), 3.23-3.12 (m, 1H), 2.55-2.30 (m, 4H), 2.06-1.90 (m, 2H), 1.81 (d, J = 
1.2 Hz, 3H), 1.75-1.61 (m, 2H), 1.43-1.31 (m, 1H), 1.21 (d, J = 6.1 Hz, 3H), 1.07 (d, J = 7.0 
Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 172.3 (C), 139.3 (C), 
136.7 (C), 133.1 (CH), 132.6 (CH), 132.3 (C), 132.0 (CH), 131.5 (CH), 128.8 (CH), 128.0 
(CH), 126.8 (CH), 83.1 (CH), 71.5 (CH), 40.0 (CH), 36.3 (CH), 33.7 (CH2), 27.8 (CH2), 26.9 
(CH2), 24.0 (CH2), 20.3 (CH3), 19.7 (CH3), 16.5 (CH3), 14.7 (CH3); IR (film): 3444, 2964, 
2928, 2873, 1725, 1492, 1444, 1373, 1339, 1252, 1221, 1196, 1149, 1086, 995, 966, 912, 873, 
759, 731, 699 cm
-1
; HRMS (ESI): m/z calcd for C25H34O3Na [M + Na]
+
: 405.2400; found 
405.2405. 
Compound S7: nBuLi (1.6 M in hexane, 0.35 mL, 0.56 mmol) was added dropwise to a 
solution of diisopropylamine (79 µL, 0.56 mmol) in THF (2 mL) at 
–78 °C. The resulting yellow solution was stirred at that temperature 
for 15 min before a solution of compound S6 (52 mg, 0.14 mmol) in 
THF (1 mL + 0.5 mL rinse) was added via canula. The resulting 
mixture was warmed to 0 °C, causing a color change to orange. 
After 10 min, the mixture was cooled to –78 °C and PhSeBr (50 mg, 
0.21 mmol) was introduced. The solution was slowly warmed to 
0 °C and stirred for 2 h before the reaction was quenched with sat. 
aq. NH4Cl. The aqueous phase was extracted with tert-butyl methyl ether, and the combined 
organic layers were dried over MgSO4 and evaporated to give the corresponding 
phenylselenide as a yellow syrup, which was directly used in the next step. 
A solution of m-chloroperbenzoic acid (70 % w/w, 69 mg, 0.28 mmol) in CH2Cl2 (0.5 mL) 
was added to a solution of the crude selenide in CH2Cl2 (3 mL) at –78 °C. After stirring for 30 
min at this temperature, diisopropylethylamine (0.14 mL, 0.84 mmol) was introduced and the 
mixture warmed to ambient temperature. After stirring for 1 h, hexane was added, the solvents 
were evaporated, and the residue was purified by flash chromatography (hexanes/EtOAc, 
90/10  80/20) to give product S7 as a yellow oil (20 mg, 38 %).  20D = –201 (c = 1, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 7.28 (t, J = 7.2 Hz, 2H), 7.18 (t, J = 7.5 Hz, 1H), 7.13 (d, 
J = 8.4 Hz, 2H), 6.78 (ddd, J = 16.2, 10.9, 5.3 Hz, 1H), 6.49 (d, J = 11.3 Hz, 1H), 5.84 (d, 
J = 15.9 Hz,1H), 5.28–5.20 (m, 2H), 5.17–5.09 (m, 2H), 3.56 (dq, J = 6.3, 6.2 Hz, 1H), 2.68–
2.60 (m, 1H), 2.52–2.37 (m, 3H), 2.37–2.22 (m, 2H), 1.73 (d, J = 1.2 Hz, 3H), 1.62 (br s, 1H), 
1.16 (d, J = 6.3 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H), 0.50 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3):  = 166.9 (C), 145.7 (CH), 140.0 (C), 137.7 (C), 133.4 (CH), 132.8 (CH), 
132.5 (CH), 132.0 (C), 130.4 (CH), 128.0 (CH), 127.9 (CH), 127.8 (CH), 126.5 (CH), 82.6 
(CH), 71.5 (CH), 40.1 (CH), 37.1 (CH), 31.6 (CH2), 27.5 (CH2), 20.2 (CH3), 16.6 (CH3), 16.5 
(CH3), 15.1 (CH3); IR (film): 3486, 2966, 2929, 2872, 1717, 1640, 1492, 1450, 1376, 1331, 
1189, 1148, 1083, 1006, 766, 703 cm
-1
; MS (EI): m/z (%):  380 (1) [M]
+
, 238 (14), 170 (100), 
155 (47), 142 (15), 91 (10), 68 (5), 41 (5); HRMS (ESI): m/z calcd for C25H32O3Na [M + 
Na]
+




Compound 54. Dess-Martin periodinane (40 mg, 0.10 mmol) was added to a solution of 
alcohol S7 (30 mg, 0.08 mmol) in CH2Cl2 (2 mL) at 0 °C. The 
mixture was stirred at ambient temperature for 30 min before the 
solvent was evaporated. The residue was purified by flash 
chromatography (hexanes/EtOAc, 90/10  80/20) to afford product 
54 as a colorless oil (22 mg, 74 %).  20D = –27 (c = 0.5, CHCl3); 
1
H 
NMR (400 MHz, CDCl3):  = 7.28 (t, J = 7.1 Hz, 2H), 7.18 (t, J = 
7.3 Hz, 1H), 7.12 (d, J = 7.8 Hz, 2H), 6.79 (ddd, J = 16.2, 10.9, 5.3 
Hz, 1H), 6.50 (d, J = 11.2 Hz, 1H), 5.83 (d, J = 15.9 Hz,1H), 5.29 
(d, J = 9.6 Hz, 1H), 5.24 (dd, J = 13.4, 4.0 Hz, 1H), 5.13 (d, J = 4.0 Hz, 1H, overlap), 5.10 
(dd, J = 11.2, 11.2 Hz, 1H, overlap), 3.47–3.37 (m, 1H), 2.69–2.60 (m, 1H), 2.55–2.39 (m, 
2H), 2.38–2.22 (m, 2H), 2.10 (s, 3H), 1.79 (d, J = 1.3 Hz, 3H), 1.16 (d, J = 6.8 Hz, 3H), 0.48 
ppm (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 209.2 (C), 166.8 (C), 145.9 (CH), 
139.9 (C), 137.7 (C), 133.7 (CH), 133.2 (C), 132.6 (CH), 130.5 (CH), 129.3 (CH), 128.1 
(CH), 128.0 (CH), 127.6 (CH), 126.5 (CH), 82.1 (CH), 46.8 (CH), 37.5 (CH), 31.7 (CH2), 
27.9 (CH3), 27.5 (CH2), 16.5 (CH3), 16.1 (CH3), 15.1 ppm (CH3); IR (film): 3402, 2971, 
2931, 2871, 1713, 1598, 1493, 1448, 1355, 1245, 1160, 1075, 1005, 765, 735, 702 cm
-1
; 
HRMS (ESI): m/z: calcd for C25H30O3Na [M + Na]
+
: 401.2087; found 401.2093. 
Compound 55. Me3SiCl (74 µL, 0.58 mmol) and triethylamine (81 µL, 0.58 mmol) were 
added to a solution of ketone 54 (22 mg, 0.058 mmol) in THF (2 mL) at –78 °C. Next, 
LiHMDS (1 M in THF, 0.12 mL, 0.12 mmol) was slowly introduced and the resulting mixture 
stirred at –78 °C for 1 h. The reaction was then quenched with pH 7 phosphate buffer and the 
product extracted with CH2Cl2 (3 x 1 mL). The combined organic phases were dried over 
MgSO4 and evaporated to give the corresponding 
silyl enol ether, which was immediately used in the 
next step without further purification. 
Molecular sieves (4 Å, ca. 200 mg) and aldehyde 
41b (9 mg, 0.058 mmol) were added to a solution of 
the crude silyl enol ether in propionitrile (2 mL). 
The mixture was cooled to –78 °C before a solution 
of compound 42 [prepared upon stirring of a 
solution of PhBCl2 (8 µL, 0.058 mmol) and N-tosyl-D-tryptophane (21 mg, 0.058 mmol) in 
CH2Cl2 (1 mL) for 1 h, followed by removal of the solvent]
3
 in propionitrile (0.5 mL) was 
introduced. After stirring for 18 h at –78 °C, the reaction was quenched with sat. aq. NaHCO3 
(2 mL), the aqueous phase extracted with CH2Cl2 (3 x 5 mL), and the combined organic 
layers were dried over MgSO4 and evaporated. The resulting crude product was dissolved in 
THF (5 mL) at 0 °C and treated with 1.5 mL of a stock solution of buffered HF∙pyridine 
[prepared from THF (7.25 mL), pyridine (2.69 mL) and HF∙pyridine complex (0.54 mL, 70 % 
w/w)]. The mixture was stirred at 0 °C for 30 min and warmed to ambient temperature for 30 
min to complete the desilylation. Dilution with CH2Cl2 (20 mL), washing of the organic layer 
with sat. aq. NaHCO3 (10 mL) and aq. CuSO4 solution (1 M, 3 x 10 mL), drying over MgSO4 
and evaporation of the solvents left a residue, which was purified by preparative TLC 
(EtOAc/hexanes, 80/20) to give product 55 as a white solid (20 mg, 65 %). The product was 
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further purified by preparative HPLC to isolate an analytically pure fraction (5 mg).  20D = –
144 (c = 0.42, CHCl3); 
1
H NMR (600 MHz, CDCl3):  = 7.86 (br s, 1H), 7.28 (t, J = 7.6 Hz, 
2H), 7.18 (t, J = 7.4 Hz, 1H), 7.11 (d, J = 8.3 Hz, 2H), 6.80 (ddd, J = 16.1, 11.0, 5.4 Hz, 1H), 
6.52 (dt, J = 11.2, 1.3 Hz, 1H), 5.82 (d, J = 16.1 Hz, 1H), 5.26 (d, J = 10.1 Hz, 1H), 5.24 
(ddd, J = 12.4, 4.1, 1.4 Hz, 1H), 5.11 (d, J = 4.4 Hz, 1H), 5.07 (dd, J = 11.3, 11.3 Hz, 1H), 
4.12–4.05 (m, 1H), 3.41 (dq, J = 9.7, 6.8 Hz, 1H), 3.22 (s, 1H), 2.77 (ddd, J = 11.4, 4.3, 1.7 
Hz, 1H), 2.74 (ddd, J = 11.5, 4.3, 1.6 Hz, 1H), 2.68–2.63 (m, 1H), 2.56–2.53 (m, 2H), 2.53–
2.40 (m, 3H), 2.36–2.25 (m, 4H), 1.77 (d, J = 1.4 Hz, 3H), 1.58 (ddd, J = 14.1, 10.6, 4.9 Hz, 
1H), 1.32–1.24 (m, 1H), 1.17 (d, J = 6.8 Hz, 3H), 0.46 ppm (d, J = 6.8 Hz, 3H); 13C NMR 
(150 MHz, CDCl3):  = 212.5 (C), 172.1 (C), 172.0 (C), 166.9 (C), 146.3 (CH), 140.0 (C), 
137.7 (C), 134.1 (CH), 134.0 (C), 132.4 (CH), 130.7 (CH), 128.5 (CH), 128.2 (CH), 128.2 
(CH), 127.7 (CH), 126.7 (CH), 81.8 (CH), 64.8 (CH), 47.4 (CH2), 46.7 (CH), 40.8 (CH2), 
38.5 (CH2), 37.5 (CH), 37.2 (CH2), 31.8 (CH2), 27.7 (CH2), 27.1 (CH), 16.7 (CH3), 16.2 
(CH3), 15.6 ppm (CH3); IR (film): 3486, 3225, 2966, 2928, 1697, 1640, 1442, 1373, 1330, 
1313, 1263, 1186, 1145, 1085, 1005, 833, 766, 733, 702 cm
-1
; HRMS (ESI): m/z: calcd for 
C32H39NO6Na [M + Na]
+
: 556.2670; found 556.2672. 
Compound 57. A solution of enyne 22 (150 mg, 0.36 mmol) and (R,R)-(–)-[1,2-
cyclohexanediamino-N,N’-bis(3,5-di-tert-butylsalicylidene]-
manganese chloride (23 mg, 0.036 mmol)
8
 in CH2Cl2 (2 mL) was 
added to an aqueous solution of NaOCl [2 mL (prepared from a 
commercial solution of bleach (0.56 mL, 2 M)] and a solution of 
Na2HPO4 (1.44 mL, 0.05 M) at 4 °C. 2 Drops of NaOH (1 M) were 
added to reach pH 11-12 and the resulting mixture was stirred for 17 
h at this temperature before a second portion of the catalyst (40 mg, 0.063 mmol) and of the 
NaOCl solution (4 mL) were added. The reaction mixture was stirred at 4 °C until TLC 
showed complete conversion. For work up, the mixture was diluted with water and CH2Cl2, 
the aqueous layer was extracted with CH2Cl2, and the combined organic layers were dried 
over MgSO4 and evaporated. The residue was purified by flash chromatography 
(hexanes/EtOAc, 10/0  95/5) to give epoxide 57 as a syrup (104 mg, 66 %).  20D = +13° 
(c = 0.55, CH2Cl2); 
1
H NMR (400 MHz, CDCl3):  = 5.40 (d, J = 9.2 Hz, 1H), 5.21 (d, J = 
3.6 Hz, 1H), 3.75 (qd, J = 6.1, 3.5 Hz, 1H), 3.47-3.46 (m, 1H), 2.85 (dd, J = 9.8, 3.8 Hz, 1H), 
2.71 (dd, J = 17.3, 12.3, 2.6 Hz, 1H), 2.46-2.33 (m, 3H), 2.33-2.17 (m, 3H), 1.79-1.69 (m, 1 
H, overlap), 1.73 (d, J = 1.3 Hz, 3 H, overlap), 1.67-1.54 (m, 2H), 1.15 (t, J = 7.1 Hz, 3H), 
1.06 (d, J = 6.2 Hz, 3H), 0.97 (d, J = 6.7 Hz, 3H), 0.95 (t, J = 7.8 Hz, 9H), 0.57 ppm (q, J = 
7.8 Hz, 6H); 
13
C NMR (100 MHz, CDCl3):  = 172.3 (C), 133.7 (CH), 128.9 (C), 87.3 (C), 
80.5 (CH), 76.6 (C), 71.4 (CH), 60.2 (CH), 46.4 (CH), 39.6 (CH), 38.4 (CH), 32.4 (CH2), 
25.8 (CH2), 23.9 (CH2), 21.2 (CH3), 18.0 (CH2), 16.4 (CH3), 15.2 (CH3), 14.7 (CH3), 7.0 
(CH3), 5.2 ppm (CH2); IR (film): 2955, 2931, 2875, 1732, 1456, 1375, 1340, 1239, 1196, 
1150, 1088, 1064, 1006, 975, 878, 833, 741, 723 cm
-1
; MS (EI): m/z (%): 161 (5), 160 (14), 
159 (100), 131 (27), 116 (6), 115 (51), 109 (9), 103 (9), 91 (8), 87 (23), 79 (5), 77 (7), 75 
(13), 67 (5), 59 (10), 55 (7), 43 (6), 41 (7), 40 (6); HRMS (ESI): m/z: calcd for C25H42O4SiNa 
[M + Na]
+
: 457.2745; found: 475.2747. 
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Compound 58: [Cp*Ru(MeCN)3]PF6 (4.3 mg, 0.0085 mmol) and benzyldimethylsilane (40 
μL, 0.26 mmol) were successively added to a solution of cycloalkyne 
57 (37 mg, 0.085 mmol) in CH2Cl2 (0.5 mL) at 0 °C. The mixture 
was stirred for 1 h at this temperature and then warmed to ambient 
temperature. Next, the solvent was slowly evaporated by a stream of 
Ar. After 30 min a second portion of [Cp*Ru(MeCN)3]PF6 (3.0 mg, 
0.006 mmol) and benzyldimethylsilane (20 μL, 0.13 mmol) were 
added and the reaction mixture was stirred until TLC indicated complete conversion (ca. 30 
min). The residue was purified by flash chromatography (hexanes/EtOAc, 90/10) to give the 
corresponding alkenylsilane, which was directly used in the next step.  
A solution of anhydrous TBAF (1 M in THF, 0.44 mL, 0.44 mmol) was added to a solution of 
this alkenylsilane in THF (0.5 mL) and the resulting mixture stirred at ambient temperature 
for 1 h and at 50 °C for 45 min. The solvent was evaporated and the residue purified by flash 
chromatography (hexanes/EtOAc, 60/40) to give alkene 58 as a colorless oil (25 mg, 91 %). 
 20D = –38° (c = 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 6.00 (dt, J = 15.8, 6.1 Hz, 
1H), 5.30 (d, J = 9.1 Hz, 1H), 5.26 (dd, J = 15.6, 8.5 Hz, 1H), 5.08 (d, J = 4.6 Hz, 1H), 3.61 
(dq, J = 6.2, 6.2 Hz, 1H), 3.46 (dd, J = 8.6, 4.2 Hz, 1H), 2.90 (dd, J = 10.1, 4.2 Hz, 1H), 
2.49-2.40 (m, 1H), 2.40-2.30 (m, 1H), 2.30-2.18 (m, 2H), 2.17-2.01 (m, 2H), 2.00-1.88 (m, 
1H), 1.73 (d, J = 1.1 Hz, 3H), 1.65-1.49 (m, 2H), 1.17 (d, J = 6.3 Hz, 3H), 1.10 (d, J = 6.9 
Hz, 3H), 0.98 ppm (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 172.7 (C), 135.5 
(CH), 133.4 (CH), 131.4 (C), 126.3 (CH), 81.4 (CH), 71.4 (CH), 60.2 (CH), 58.3 (CH), 39.9 
(CH), 36.0 (CH), 33.4 (CH2), 30.5 (CH2), 25.4 (CH2), 23.5 (CH2), 20.4 (CH3), 16.4 (CH3), 
15.5 (CH3), 14.9 ppm (CH3); IR (film): 3491, 2968, 2931, 1727, 1454, 1375, 1336, 1255, 
1202, 1170, 1147, 1089, 973, 933, 874, 825 cm
-1
; HRMS (ESI): m/z: calcd for C19H30O4Na 
[M + Na]
+
: 345.2036; found: 345.2035. 
Compounds 59 and 60: A solution of p-TsOH (0.2 mg, 0.0011 mmol) in methanol (0.1 mL) 
was added to a solution of 
epoxide 58 (7.0 mg, 0.022 mmol) 
in methanol (0.3 mL) at 0 °C. The 
mixture was stirred for 45 min at 
this temperature and then directly 
purified by flash chromatography 
(hexanes/EtOAc, 80/20  70/30) 
to give compound 59 (2.5 mg, 32 %) and compound 60 (4.0 mg, 52 %) as a colorless oil each. 
Spectral data of compound 59: 
1
H NMR (600 MHz, CDCl3):  = 5.62 (ddd, J = 15.7, 9.3, 4.1 
Hz, 1H), 5.43 (dd, J = 15.8, 7.9 Hz, 1H), 5.13 (s, 1H), 4.95 (d, J = 10.1 Hz, 1H), 3.82 (d, J = 
7.4 Hz, 1H), 3.72 (dd, J = 6.0, 2.1 Hz, 1H), 3.36 (dq, J = 6.2, 7.3 Hz, 1H), 3.25 (s, 3H), 2.37-
2.29 (m, 2H), 2.22-2.15 (m. 2H), 2.13-2.06 (m, 2H), 1.84-1.70 (m, 2H), 1.68 (d, J = 1.2 Hz, 
3H), 1.63-1.54 (m, 4H), 1.13 (d, J = 6.1 Hz, 3H), 0.97 (d, J = 7.2 Hz, 3H), 0.91 ppm (d, J = 
6.7 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  = 173.2 (C), 136.0 (CH), 135.1 (C), 128.4 (CH), 
127.1 (CH), 84.5 (CH), 77.2 (CH), 76.8 (CH), 71.8 (CH), 56.5 (CH3), 40.3 (CH), 37.2 (CH), 
34.7 (CH2), 30.0 (CH2), 28.9 (CH2), 22.8 (CH2), 19.9 (CH3), 16.8 (CH3), 14.6 (CH3), 11.1 
ppm (CH3); IR (film): 3433, 2967, 2928, 1727, 1448, 1373, 1251, 1188, 1155, 1092, 1042, 
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1013, 983, 969, 919, 703 cm
-1
; MS (EI): m/z (%): 183 (10), 172 (30), 171 (100), 169 (13), 154 
(20), 153 (17), 151 (23), 139 (25), 137 (11), 126 (10), 125 (15), 123 (11), 121 (19), 112 (35), 
111 (15), 110 (37), 109 (56), 97 (25), 95 (29), 94 (10), 93 (11), 81 (10), 79 (16), 71 (28), 69 
(15), 67 (14), 55 (15), 45 (11), 43 (18), 41 (14); HRMS (ESI): m/z: calcd for C20H34O5Na [M 
+ Na]
+
: 377.2298; found: 377.2297.  
Spectral data of compound 60: 
1
H NMR (400 MHz, CDCl3):  = 6.00 (dd, J = 15.8, 1.9 Hz, 
1H), 5.38 (ddd, J = 15.7, 9.3, 2.2 Hz, 1H), 5.01 (s, 1H), 4.89 (d, J = 10.4 Hz, 1H), 4.43-4.38 
(m, 1H), 3.79 (td, J = 9.9, 5.8 Hz, 1H), 3.33 (dq. J = 6.8, 6.4 Hz, 1H), 3.26 (s, 3H), 2.48 (dt, 
J = 13.1, 4.2 Hz, 1H), 2.41-2.30 (m, 1H), 2.15-2.02 (m, 2H), 1.85-1.52 (m, 4 H, overlap), 
1.69 (d, J = 0.9 Hz, 3 H, overlap) 1.47-1.41 (m, 2H), 1.41-1.36 (m, 2H), 1.15 (d, J = 6.0 Hz, 
3H), 1.03 (d, J = 7.4 Hz, 3H), 0.93 ppm (d, J = 6.6 Hz, 3H); 
13
C NMR (101 MHz, CDCl3): 
 = 173.9 (C), 137.1 (C), 134.7 (CH), 126.5 (CH), 125.6 (CH), 82.2 (CH), 74.5 (CH), 72.4 
(CH), 72.0 (CH), 56.2 (CH3), 40.7 (CH), 40.6 (CH), 35.9 (CH2), 31.2 (CH2), 24.0 (CH2), 22.0 
(CH2), 20.0 (CH3), 17.1 (CH3), 15.5 (CH3), 10.1 ppm (CH3). 
Compound 62. p-TsOH (17 mg, 0.09 mmol) was added to a solution of epoxide 57 (79 mg, 
0.18 mmol) in methanol (6 mL). The mixture was heated to 60 °C for 
2 h before the solvent was evaporated. The residue was purified by 
flash chromatography (hexanes/EtOAc, 60/40) to give compound 62 
as a pale yellow oil (60 mg, 94 %).  20D = +70° (c = 1.0, CHCl3); 
1
H 
NMR (400 MHz, CDCl3):  = 5.18 (d, J = 2.7 Hz, 1H), 5.07 (dt, J = 
9.3, 0.9 Hz, 1H), 4.03 (dd, J = 9.7, 1.4 Hz, 1H), 3.64-3.58 (m, 1H), 
3.41 (s, 3H), 3.37 (dq, J = 8.6, 6.1 Hz, 1H), 2.89 (br s , 1H), 2.58 (ddd, J = 13.9, 7.1, 2.4 Hz, 
1H), 2.41-2.30 (m, 2H), 2.25-2.14 (m, 2H), 2.10-1.96 (m, 2H), 1.81 (d, J = 1.1 Hz, 3H), 1.80-
1.64 (m, 2H), 1.53-1.40 (m, 1H), 1.17 (d, J = 6.1 Hz, 3H), 0.96 (d, J = 7.2 Hz, 3H), 0.92 ppm 
(d, J = 6.7 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 172.4 (C), 133.4 (C), 130.9 (CH), 89.0 
(C), 79.5 (CH), 77.8 (C), 73.9 (CH), 72.4 (CH), 72.2 (CH), 57.1 (CH3), 40.9 (CH), 39.5 (CH), 
34.7 (CH2), 27.0 (CH2), 23.7 (CH2), 20.1 (CH3), 18.4 (CH2), 16.8 (CH3), 13.9 (CH3), 10.9 
(CH3); IR (film): 3450, 2924, 2854, 1728, 1452, 1376, 1252, 1146, 1101, 1046, 983, 904, 832, 
761, 699 cm
-1
; HRMS (ESI): m/z: calcd for C20H32O5Na [M + Na]
+
: 375.2142; found: 
375.2143. 
Compound 63: Dess-Martin periodinane (119 mg, 0.28 mmol) was added to a solution of 
alcohol 62 (50 mg, 0.14 mmol) in CH2Cl2 (3 mL) at 0 °C. After 
stirring for 3 h at this temperature, the solvent was slowly 
evaporated by a stream of Ar and the residue purified by flash 
chromatography (hexanes/EtOAc, 80/20  70/30) to give ketone 63 
as a white solid (36 mg, 73 %). M.p.: 131-132 °C;  20D = +285° (c = 
1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 5.20 (d, J = 9.7 Hz, 
1H), 5.15 (d, J = 3.6 Hz, 1H), 3.99 (dd, J = 9.7, 2.0 Hz, 1H), 3.60 (dq, J = 9.5, 1.1 Hz, 1H), 
3.43 (s, 3H), 3.43-3.35 (m, 1H), 2.74 (br s, 1H), 2.57 (ddd, J = 14.9, 8.1, 2.4 Hz, 1H), 2.36 
(ddt, J = 17.1, 7.1, 2.7 Hz, 1H), 2.27-2.16 (m, 2H), 2.15-2.04 (m, 1 H, overlap), 2.11 (s, 3 H, 
overlap), 2.03-1.91 (m, 1H), 1.84 (d, J = 1.1 Hz, 3H), 1.82-1.75 (m, 1H), 1.73-1.61 (m, 1H), 
1.57-1.45 (m, 1H), 1.11 (d, J = 6.6 Hz, 3H), 0.93 ppm (d, J = 7.3 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3):  = 209.6 (C), 172.1 (C), 134.3 (C), 127.3 (CH), 88.6 (C), 79.4 (CH), 77.7 (C), 
S33 
 
74.1 (CH), 71.6 (CH), 56.8 (CH3), 46.6 (CH), 39.0 (CH), 34.2 (CH2), 28.0 (CH3), 26.8 (CH2), 
23.3 (CH2), 18.1 (CH2), 15.8 (CH3), 13.5 (CH3), 10.7 ppm (CH3); IR (film): 3534, 2931, 
2873, 1717, 1703, 1445, 1409, 1346, 1328, 1312, 1248, 1223, 1167, 1143, 1107, 1039, 979, 
875, 760 cm
-1
; MS (EI): m/z (%): 350 (2) [M+], 181 (11), 170 (15), 169 (100), 149 (11), 137 
(37), 125 (12), 123 (23), 121 (28), 111 (15), 110 (10), 109 (82), 95 (16), 93 (21), 92 (10), 91 
(23), 85 (65), 84 (62), 81 (20), 79 (31), 77 (15), 69 (19), 67 (21), 55 (20), 53 (13), 43 (67), 41 
(24); HRMS (ESI): m/z: calcd for C20H30O5Na [M + Na]
+
: 373.1985; found: 373.1984. 
Compound 61b. Ph3SnH (200 mg, 0.57 mmol) and AIBN (7 mg, 0.042 mmol) were added to 
a solution of alkyne 62 (50 mg, 0.14 mmol) in degassed toluene (6 
mL). The mixture was stirred at 80 °C for 4 h before additional  
Ph3SnH (50 mg, 0.14 mmol) and AIBN (7 mg, 0.042 mmol) were 
added. After stirring for 7 h at this temperature, the solvent was 
evaporated and the residue was purified by flash chromatography 
(hexanes/EtOAc, 90/10  80/20) to give stanane 61b (64 mg, 65 %) 
as a colorless oil.  20D = +13.4° (c = 0.79, CHCl3); 
1
H NMR (400 
MHz, CDCl3):  = 7.63-7.55 (m, 6H), 7.43-7.31 (m, 9H), 6.77 (t, J = 7.8 Hz, 1H), 5.19 (d, J = 
2.5 Hz, 1H), 5.04 (d, J = 10.0 Hz, 1H), 3.91 (d, J = 9.0 Hz, 1H), 3.61 (d, J = 9.0 Hz, 1H), 
3.38-3.29 (m, 1H), 3.20 (br s, 1H), 3.14 (s, 3H), 2.88 (br s, 1H), 2.41-2.28 (m, 2H), 2.20-2.03 
(m, 3H), 2.03-1.88 (m, 1H), 1.80 (d, J = 0.8 Hz, 3H), 1.74-1.60 (m, 2H), 1.48-1.30 (m, 2H), 
1.18 (d, J = 6.0 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H), 0.78 ppm (d, J = 7.3 Hz, 3H); 
13
C NMR 
(101 MHz, CDCl3):  = 171.9, 148.2, 142.0, 138.7, 137.2, 133.3, 131.1, 129.1, 128.9, 85.4, 
79.6, 73.2, 72.5, 57.2, 40.8, 38.6, 35.1, 32.3, 28.2, 21.9, 19.9, 16.7, 13.5, 10.7 ppm; IR (film): 
3499, 2928, 1728, 429, 1251, 1094, 1073, 1044, 977, 729, 699 cm
-1
; MS (EI): m/z (%): 628 
(10), 627 (31), 626 (16), 625 (24), 624 (11), 623 (13), 445 (17), 444 (12), 443 (32), 442 (16), 
441 (29), 440 (12), 439 (16), 367 (19), 366 (13), 365 (25), 364 (14), 363 (22), 361 (10), 355 
(19), 353 (16), 352 (19), 351 (100), 350 (39), 349 (76), 348 (30), 347 (43), 289 (12), 287 (10), 
275 (12), 197 (23), 195 (18), 194 (15), 193 (10), 109 (14); HRMS (ESI): m/z: calcd for 
C38H48O5SnNa [M + Na]
+
: 727.2415; found: 727.2424. 
Compound 61a: Iodine (19 mg, 0.073 mmol) was added to a solution of stanane 61b (43 mg, 
0.061 mmol) in CH2Cl2 (2 mL) at –78 °C. After 10 min, the reaction 
was warmed to ambient temperature and stirred for 20 min before 
the solvent was slowly evaporated by a stream of Ar. The residue 
was purified by flash chromatography (hexanes/EtOAc, 80/20  
70/30) to give iodide 61c as a yellow oil (24 mg, 82 %).  
Bu3SnH (22 μL, 0.082 mmol) and AIBN (4 mg, 0.024 mmol) were successively added to a 
solution  of this iodide in degassed toluene (1 mL). The mixture was stirred at 65 °C for 2 h 
prior to evaporation of the solvent. The residue was purified by flash chromatography 
(hexanes/EtOAc, 80/20  60/40) to give alkene 61a as a colorless oil (12 mg, 63 %).  20D  = 
+44° (c = 0.5, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 5.66 (ddd, J = 15.8, 8.6, 6.9 Hz, 
1H), 5.26 (dd, J = 16.0, 7.1 Hz, 1H), 5.11 (d, J = 2.3 Hz, 1H), 5.06 (d, J = 10.0 Hz, 1H), 3.67 
(dd, J = 9.4, 1.3 Hz, 1H), 3.43-3.34 (m, 1H), 3.32-3.23 (m, 1 H, overlap), 3.30 (s, 3H), 3.14 
(br s, 1H), 3.09 (br s, 1H), 2.46 (dt, J = 13.5, 4.5 Hz, 1H), 2.41-2.30 (m, 1H), 2.26-2.17 (m, 
1H), 2.15-2.06 (m, 1H), 1.94-1.86 (m, 1H), 1.82 (d, J = 1.1 Hz, 3H), 1.78-1.55 (m, 5H), 1.18 
S34 
 
(d, J = 6.3 Hz, 3H), 0.97 (d, J = 7.3 Hz, 3H), 0.93 ppm (d, J = 6.7 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3):  = 172.4 (C), 135.4 (CH), 133.2 (C), 130.9 (CH), 130.3 (CH), 82.2 (CH), 79.5 
(CH), 72.4 (CH), 71.7 (CH), 56.6 (CH3), 40.8 (CH), 38.3 (CH), 34.9 (CH2), 30.2 (CH2), 26.5 
(CH2), 22.4 (CH2), 20.0 (CH3), 16.7 (CH3), 13.8 (CH3), 10.9 ppm (CH3); IR (film): 3481, 
2926, 2855, 1729, 1452, 1377, 1252, 1190, 1142, 1100, 1041, 982 cm
-1
; MS (EI): m/z (%): 
278 (25), 172 (18), 171 (100), 170 (12), 169 (15), 154 (24), 153 (19), 151 (28), 139 (21), 137 
(19), 126 (26), 125 (14), 123 (17), 121 (21), 112 (17). 11 (25), 110 (40), 109 (69), 107 (10), 
98 (16), 97 (54), 96 (22), 95 (37), 94 (22), 93 (23), 91 (10), 81 (20), 79 (31), 71 (45), 69 (26), 
67 (34), 57 (15), 55 (35), 53 (11), 45 (25), 43 (36), 41 (38); HRMS (ESI): m/z: calcd for 
C20H34O5Na [M + Na]
+
: 377.2298; found: 377.2299. 
Compound 65: Dess-Martin periodinane (45 mg, 0.11 mmol) was added to a solution of 
alcohol 61a (15 mg, 0.042 mmol) in CH2Cl2 (2 mL) at 0 °C. After 
stirring for 4 h at this temperature, the solvent was evaporated and the 
residue purified by flash chromatography (hexanes/EtOAc, 80/20  
70/30) to give ketone 65 as a white solid (10 mg, 68 %).  20D  = 
+192° (c = 0.5, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 5.68 (dt, 
J = 15.5, 7.4 Hz, 1H), 5.30 (dd, J = 16.0, 6.9 Hz, 1H), 5.19 (d, J = 9.6 Hz, 1H), 5.05 (d, J = 
3.0 Hz, 1H), 3.65 (dd, J = 9.3, 2.8 Hz, 1H), 3.40 (dq, J = 9.6, 6.8 Hz, 1H), 3.31 (s, 3H), 3.31-
3.23 (m, 1H), 2.99 (br s, 1H), 2.46-2.38 (m, 1H), 2.27-2.15 (m, 2H), 2.11 (s, 3H), 1.98-1.89 
(m, 2H), 1.83 (d, J = 1.0 Hz, 3H), 1.78-1.66 (m, 3H), 1.40-1.27 (m, 1H), 1.12 (d, J = 6.8 Hz, 
3H), 0.95 ppm (d, J = 7.3 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  = 209.8 (C), 172.3 (C), 
135.5 (CH), 134.3 (C), 129.5 (CH), 127.0 (CH), 82.6 (CH), 79.3 (CH), 72.2 (CH), 56.5 
(CH3), 46.6 (CH), 38.2 (CH), 34.4 (CH2), 30.2 (CH2), 28.1 (CH3), 26.5 (CH2), 22.6 (CH3), 
15.9 (CH3), 13.7 (CH3), 11.0 ppm (CH3); IR (film): 3526, 2931, 1715, 1449, 1430, 1355, 
1251, 1185, 1151, 1102, 1040, 981, 872, 731, 699 cm
-1
; MS (EI): m/z (%): 181 (7), 172 (10), 
171 (100), 155 (7), 154 (19), 153 (20), 151 (6), 139 (23), 126 (7), 125 (8), 123 (9), 121 (24), 
111 (13), 110 (19), 109 (31), 98 (5), 97 (20), 95 (11), 94 (10), 93 (10), 81 (7), 79 (15), 71 
(22), 69 (8), 67 (12), 57 (6), 55 (11), 45 (7), 43 (31), 41 (13); HRMS (ESI): m/z: calcd for 
C20H32O5Na [M + Na]
+
: 375.2142; found: 375.2138. 
Compound 56: Me3SiCl (18 μL, 0.14 mmol) and triethylamine (20 μL, 0.14 mmol) were 
added to a solution of ketone 65 (5.0 mg, 0.014 
mmol) in THF (0.5 mL) at –78 °C. Next, LiHMDS (1 
M in THF, 84 μL, 0.084 mmol) was slowly 
introduced and the resulting mixture stirred at –78 °C 
for 1 h. The reaction was then quenched with pH 7 
phosphate buffer and the product extracted with 
CH2Cl2 (3 x 2 mL). The combined organic phases were dried over MgSO4 and evaporated to 
give the corresponding silyl enol ether, which was used in the next step without further 
purification. 
Molecular sieves (4 Å, ca. 100 mg) and aldehyde 41b (2.2 mg, 0.014 mmol) were added to a 
solution of the crude silyl enol ether in propionitrile (0.4 mL). The mixture was cooled to       
–78 °C before a solution of compound 42 [prepared upon stirring of a solution of PhBCl2 (1.8 
µL, 0.014 mmol) and N-tosyl-D-tryptophane (5 mg, 0.014 mmol) in CH2Cl2 (0.5 mL) for 1 h, 
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followed by removal of the solvent]
3
 in propionitrile (0.1 mL) was added. After stirring for 18 
h at –78 °C, the reaction was quenched with sat. aq. NaHCO3, the aqueous phase was 
extracted with CH2Cl2 (3 x 2 mL), and the combined organic layers were dried over Na2SO4 
and evaporated. The resulting crude product was dissolved in THF (4 mL) at 0 °C and treated 
with 0.5 mL of buffered HF∙pyridine solution [prepared from THF (3.6 mL), pyridine (1.35 
mL) and HF∙pyridine complex (0.27 mL, 70 % w/w)]. The mixture was stirred at 0 °C for 1 h 
and warmed to ambient temperature for 30 min, before a second portion of buffered 
HF∙pyridine solution (0.5 mL) was added and the solvent was slowly evaporated by a stream 
of Ar. After stirring of the remaining syrup for 2h, the mixture was diluted with CH2Cl2, the 
organic phase was washed with sat. aq. NaHCO3 and CuSO4 solution (1 M) before it was 
dried over Na2SO4 and evaporated. The residue was purified by flash chromatography 
(EtOAc/hexanes, 8/2) to give product 56 as a white solid (2.1 mg, 30 %).  20D  = +129° (c = 
0.4, CHCl3); 
1
H NMR (600 MHz, CDCl3):  = 7.76 (s, 1H), 5.66 (ddd, J = 16.0, 7.2, 7.2 Hz, 
1H), 5.26 (dd, J = 16.0, 7.0 Hz, 1H), 5.06 (d, J = 9.6 Hz, 1H), 5.03 (d, J = 2.9 Hz, 1H), 4.06-
4.00 (m, 1H), 3.63 (dd, J = 9.4, 2.4 Hz, 1H), 3.39 (dq, J = 9.7, 6.7 Hz, 1H), 3.30 (s, 3H), 3.27 
(dd, J = 7.0, 9.2 Hz, 1H), 2.77 (dd, J = 17.1, 4.0,  Hz, 1H), 2.73 (dd, J = 17.1, 4.0 Hz, 1H), 
2.66 (dd, J = 17.7, 8.5 Hz, 1H), 2.48 (dd, J = 17.7, 2.9 Hz, 1H), 2.46-2.38 (m, 2H), 2.30 (dd, 
J = 17.1, 10.9 Hz, 1H), 2.28 (dd, J = 17.1, 10.7 Hz, 1H), 2.23-2.16 (m, 1H), 2.16-2.10 (m, 
1H), 1.94-1.88 (m, 1H), 1.88-1.83 (m, 1H), 1.82 (d, J = 1.2 Hz, 3H), 1.75-1.66 (m, 3H), 1.55 
(ddd, J = 14.0, 10.2, 5.1 Hz, 1H), 1.36 (ddd, J = 14.0, 8.8, 3.1 Hz, 1H), 1.32-1.24 (m, 1H), 
1.11 (d, J = 6.7 Hz, 3H), 0.90 ppm (d, J = 7.2 Hz, 3H); 
13
C NMR (150 MHz, CDCl3):  = 
212.2, 172.5, 172.2, 171.9, 135.9, 135.2, 129.7, 126.5, 82.5, 79.3, 72.2, 65.1, 56.6, 47.4, 46.7, 
41.1, 38.6, 38.3, 37.3, 34.7, 30.3, 27.2, 26.5, 22.7, 15.6, 13.9, 11.2 ppm; IR (film): 2981, 
2934, 1733, 1591, 1490, 1380, 1360, 1276, 1183, 1135, 1100, 1052, 1024, 1003, 979, 769, 
689 cm
-1
; HRMS (ESI): m/z: calcd for C27H41NO8Na [M + Na]
+
: 530.2724; found: 530.2727. 
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